|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
|
Wisconsin
|
|
39-0168610
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
(Title of each class)
|
|
(Name of each exchange on
which registered)
|
|
|
|
Class A Common Stock, par value $0.20 per share
|
|
New York Stock Exchange
|
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
|
|
|
|
|
|
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
|
|
|
|
|
|
|
|
|
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
|
|
|
|
|
|
|
|
|
Item 15.
|
|
|
|
2018
|
|
2017
|
|
||
|
Quarter 1 (September - November)
|
|
24
|
%
|
|
24
|
%
|
|
|
Quarter 2 (December - February)
|
|
23
|
%
|
|
24
|
%
|
|
|
Quarter 3 (March - May)
|
|
27
|
%
|
|
27
|
%
|
|
|
Quarter 4 (June - August)
|
|
26
|
%
|
|
25
|
%
|
|
|
|
|
100
|
%
|
|
100
|
%
|
|
Name
|
|
Age
|
|
Position
|
Randal W. Baker
|
|
55
|
|
President and Chief Executive Officer
|
Rick T. Dillon
|
|
47
|
|
Executive Vice President and Chief Financial Officer
|
Fabrizio R. Rasetti
|
|
52
|
|
Executive Vice President—General Counsel and Secretary
|
Roger A. Roundhouse
|
|
53
|
|
Executive Vice President—Engineered Components & Systems Segment
|
J. Jeffrey Schmaling
|
|
59
|
|
Executive Vice President—Industrial Tools & Services Segment
|
Andre L. Williams
|
|
59
|
|
Executive Vice President—Global Human Resources
|
•
|
difficulties in integrating and managing personnel, financial reporting and other systems used by the acquired businesses;
|
•
|
the failure of acquired businesses to perform in accordance with our expectations;
|
•
|
failure to achieve anticipated synergies between our business units and the business units of acquired businesses;
|
•
|
the loss of customers of acquired businesses;
|
•
|
the loss of key managers of acquired businesses; or
|
•
|
other material adverse events in the acquired businesses.
|
|
|
Number of Locations
|
|
Square Footage
|
||||||||||||||
|
|
|
|
Distribution /
Sales /
Admin
|
|
|
|
|
||||||||||
|
|
Manufacturing
|
|
Total
|
|
Owned
|
|
Leased
|
|
Total
|
||||||||
Industrial Tools & Services
|
|
13
|
|
|
31
|
|
|
44
|
|
|
228
|
|
|
1,102
|
|
|
1,330
|
|
Engineered Components & Systems
|
|
17
|
|
|
6
|
|
|
23
|
|
|
823
|
|
|
1,013
|
|
|
1,836
|
|
Corporate and other
|
|
1
|
|
|
5
|
|
|
6
|
|
|
353
|
|
|
165
|
|
|
518
|
|
|
|
31
|
|
|
42
|
|
|
73
|
|
|
1,404
|
|
|
2,280
|
|
|
3,684
|
|
Item 5.
|
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
Fiscal Year
|
|
Period
|
|
High
|
|
Low
|
||||
2018
|
|
June 1, 2018 to August 31, 2018
|
|
$
|
29.75
|
|
|
$
|
23.55
|
|
|
|
March 1, 2018 to May 31, 2018
|
|
25.05
|
|
|
22.05
|
|
||
|
|
December 1, 2017 to February 28, 2018
|
|
27.50
|
|
|
22.50
|
|
||
|
|
September 1, 2017 to November 30, 2017
|
|
27.00
|
|
|
24.30
|
|
||
2017
|
|
June 1, 2017 to August 31, 2017
|
|
$
|
27.40
|
|
|
$
|
22.25
|
|
|
|
March 1, 2017 to May 31, 2017
|
|
28.90
|
|
|
24.55
|
|
||
|
|
December 1, 2016 to February 28, 2017
|
|
29.30
|
|
|
21.60
|
|
||
|
|
September 1, 2016 to November 30, 2016
|
|
24.19
|
|
|
21.68
|
|
|
|
8/13
|
|
8/14
|
|
8/15
|
|
8/16
|
|
8/17
|
|
8/18
|
||||||||||||
Actuant Corporation
|
|
$
|
100.00
|
|
|
$
|
94.53
|
|
|
$
|
60.16
|
|
|
$
|
67.02
|
|
|
$
|
67.75
|
|
|
$
|
83.10
|
|
S&P 500
|
|
100.00
|
|
|
125.25
|
|
|
125.84
|
|
|
141.64
|
|
|
164.64
|
|
|
197.01
|
|
||||||
Dow Jones US Diversified Industrials
|
|
100.00
|
|
|
119.37
|
|
|
119.23
|
|
|
150.89
|
|
|
149.18
|
|
|
133.71
|
|
|
|
Year Ended August 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
|
(in millions, except per share data)
|
||||||||||||||||||
Statement of Earnings Data
(1)(2)
:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
1,183
|
|
|
$
|
1,096
|
|
|
$
|
1,149
|
|
|
$
|
1,249
|
|
|
$
|
1,400
|
|
Gross profit
|
|
415
|
|
|
380
|
|
|
403
|
|
|
462
|
|
|
547
|
|
|||||
Selling, administrative and engineering expenses
|
|
292
|
|
|
278
|
|
|
274
|
|
|
300
|
|
|
332
|
|
|||||
Amortization of intangible assets
|
|
21
|
|
|
20
|
|
|
23
|
|
|
24
|
|
|
25
|
|
|||||
Loss (gain) on product line divestiture
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
(13
|
)
|
|||||
Director & officer transition charges
|
|
—
|
|
|
8
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Restructuring charges
|
|
12
|
|
|
7
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|||||
Impairment & divestiture charges
|
|
73
|
|
|
117
|
|
|
187
|
|
|
84
|
|
|
—
|
|
|||||
Operating profit (loss)
|
|
18
|
|
|
(50
|
)
|
|
(100
|
)
|
|
54
|
|
|
203
|
|
|||||
(Loss) earnings from continuing operations
|
|
(22
|
)
|
|
(66
|
)
|
|
(105
|
)
|
|
20
|
|
|
141
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Diluted (loss) earnings per share from continuing operations
|
|
$
|
(0.36
|
)
|
|
$
|
(1.11
|
)
|
|
$
|
(1.78
|
)
|
|
$
|
0.32
|
|
|
$
|
1.95
|
|
Cash dividends per share declared
|
|
$
|
0.04
|
|
|
$
|
0.04
|
|
|
$
|
0.04
|
|
|
$
|
0.04
|
|
|
$
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Diluted weighted average common shares
|
|
60,441
|
|
|
59,436
|
|
|
59,010
|
|
|
62,055
|
|
|
72,486
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Balance Sheet Data
(at end of period)
(2)
:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash
|
|
$
|
250
|
|
|
$
|
230
|
|
|
$
|
180
|
|
|
$
|
169
|
|
|
$
|
109
|
|
Assets
|
|
1,481
|
|
|
1,517
|
|
|
1,439
|
|
|
1,637
|
|
|
1,857
|
|
|||||
Debt
|
|
533
|
|
|
562
|
|
|
580
|
|
|
588
|
|
|
390
|
|
|||||
Net debt (debt less cash)
|
|
283
|
|
|
332
|
|
|
400
|
|
|
419
|
|
|
281
|
|
(1)
|
Results are from continuing operations and exclude the financial results of previously divested businesses reported as discontinued operations (former Electrical segment) in fiscal 2014.
|
(2)
|
We have completed various acquisitions that impact the comparability of the selected financial data. The results of operations for these acquisitions are included in our financial results for all periods subsequent to their acquisition date. The following table summarizes the acquisitions that were completed during the last five fiscal years (amounts in millions):
|
|
|
|
|
|
|
|
|
|
|||
Acquisition
|
|
Segment
|
|
Date Completed
|
|
Sales
(a)
|
|
Purchase Price
|
|||
Equalizer
|
|
Industrial Tools & Services
|
|
May 2018
|
|
$
|
6
|
|
|
6
|
|
Mirage Machines
|
|
Industrial Tools & Services
|
|
December 2017
|
|
12
|
|
|
17
|
|
|
Pipeline and Process Services
(b)
|
|
Industrial Tools & Services
|
|
March 2016
|
|
32
|
|
|
66
|
|
|
Larzep, S.A.
|
|
Industrial Tools & Services
|
|
February 2016
|
|
8
|
|
|
16
|
|
|
Hayes Industries, Ltd.
|
|
Engineered Components & Systems
|
|
May 2014
|
|
25
|
|
|
31
|
|
|
|
Year Ended August 31,
|
|||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||||||
Statements of Earnings Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net sales
|
|
$
|
1,183
|
|
|
100
|
%
|
|
$
|
1,096
|
|
|
100
|
%
|
|
$
|
1,149
|
|
|
100
|
%
|
Cost of products sold
|
|
767
|
|
|
65
|
%
|
|
716
|
|
|
65
|
%
|
|
746
|
|
|
65
|
%
|
|||
Gross profit
|
|
416
|
|
|
35
|
%
|
|
380
|
|
|
35
|
%
|
|
403
|
|
|
35
|
%
|
|||
Selling, administrative and engineering expenses
|
|
292
|
|
|
25
|
%
|
|
278
|
|
|
25
|
%
|
|
274
|
|
|
24
|
%
|
|||
Amortization of intangible assets
|
|
21
|
|
|
2
|
%
|
|
20
|
|
|
2
|
%
|
|
23
|
|
|
2
|
%
|
|||
Loss on product line divestiture
|
|
—
|
|
|
0
|
%
|
|
—
|
|
|
0
|
%
|
|
5
|
|
|
0
|
%
|
|||
Director & officer transition charges
|
|
—
|
|
|
0
|
%
|
|
8
|
|
|
1
|
%
|
|
—
|
|
|
0
|
%
|
|||
Restructuring charges
|
|
12
|
|
|
1
|
%
|
|
7
|
|
|
1
|
%
|
|
15
|
|
|
1
|
%
|
|||
Impairment & divestiture charges
|
|
73
|
|
|
6
|
%
|
|
117
|
|
|
11
|
%
|
|
187
|
|
|
16
|
%
|
|||
Operating profit (loss)
|
|
18
|
|
|
2
|
%
|
|
(50
|
)
|
|
(5
|
)%
|
|
(100
|
)
|
|
(9
|
)%
|
|||
Financing costs, net
|
|
31
|
|
|
3
|
%
|
|
30
|
|
|
3
|
%
|
|
29
|
|
|
3
|
%
|
|||
Other (income) expense, net
|
|
(1
|
)
|
|
0
|
%
|
|
3
|
|
|
0
|
%
|
|
1
|
|
|
0
|
%
|
|||
Loss before income tax expense (benefit)
|
|
(12
|
)
|
|
(1
|
)%
|
|
(83
|
)
|
|
(8
|
)%
|
|
(130
|
)
|
|
(11
|
)%
|
|||
Income tax expense (benefit)
|
|
9
|
|
|
1
|
%
|
|
(17
|
)
|
|
(2
|
)%
|
|
(25
|
)
|
|
(2
|
)%
|
|||
Net loss
|
|
$
|
(21
|
)
|
|
(2
|
)%
|
|
$
|
(66
|
)
|
|
(6
|
)%
|
|
$
|
(105
|
)
|
|
(9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Other Financial Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Depreciation
|
|
$
|
20
|
|
|
|
|
$
|
23
|
|
|
|
|
$
|
25
|
|
|
|
|||
Capital expenditures
|
|
21
|
|
|
|
|
28
|
|
|
|
|
20
|
|
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net Sales
|
|
$
|
591
|
|
|
$
|
553
|
|
|
$
|
588
|
|
Operating Profit
|
|
99
|
|
|
96
|
|
|
120
|
|
|||
Operating Profit %
|
|
16.8
|
%
|
|
17.3
|
%
|
|
20.4
|
%
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net Sales
|
|
$
|
592
|
|
|
$
|
543
|
|
|
$
|
561
|
|
Operating Loss
(1)
|
|
(52
|
)
|
|
(113
|
)
|
|
(191
|
)
|
|||
Operating Loss %
|
|
(8.8
|
)%
|
|
(20.8
|
)%
|
|
(34.0
|
)%
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Loss before income tax expense (benefit)
|
|
$
|
(12,672
|
)
|
|
$
|
(82,691
|
)
|
|
$
|
(130,344
|
)
|
Income tax expense (benefit)
|
|
8,976
|
|
|
(16,478
|
)
|
|
(25,170
|
)
|
|||
Effective income tax rate
|
|
(70.8
|
)%
|
|
19.9
|
%
|
|
19.3
|
%
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net cash provided by operating activities
|
|
$
|
106
|
|
|
$
|
88
|
|
|
$
|
118
|
|
Net cash used in investing activities
|
|
(63
|
)
|
|
(28
|
)
|
|
(83
|
)
|
|||
Net cash used in financing activities
|
|
(18
|
)
|
|
(15
|
)
|
|
(18
|
)
|
|||
Effect of exchange rate changes on cash
|
|
(4
|
)
|
|
4
|
|
|
(5
|
)
|
|||
Net increase in cash and cash equivalents
|
|
$
|
21
|
|
|
$
|
49
|
|
|
$
|
11
|
|
|
|
August 31, 2018
|
|
August 31, 2017
|
||||||||||
|
|
$
|
|
PWC %
|
|
$
|
|
PWC %
|
||||||
Accounts receivable, net
|
|
$
|
188
|
|
|
16
|
%
|
|
$
|
190
|
|
|
17
|
%
|
Inventory, net
|
|
156
|
|
|
13
|
%
|
|
144
|
|
|
13
|
%
|
||
Accounts payable
|
|
(131
|
)
|
|
(11
|
)%
|
|
(133
|
)
|
|
(12
|
)%
|
||
Net primary working capital
|
|
$
|
213
|
|
|
18
|
%
|
|
$
|
201
|
|
|
18
|
%
|
|
|
Payments Due
|
||||||||||||||||||||||||||
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
|
Total
|
||||||||||||||
Debt (short-term and long-term)
|
|
$
|
30
|
|
|
$
|
218
|
|
|
$
|
—
|
|
|
$
|
288
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
536
|
|
Interest on long-term debt
|
|
26
|
|
|
25
|
|
|
16
|
|
|
14
|
|
|
—
|
|
|
—
|
|
|
81
|
|
|||||||
Operating leases
|
|
29
|
|
|
21
|
|
|
15
|
|
|
13
|
|
|
11
|
|
|
35
|
|
|
124
|
|
|||||||
Deferred acquisition purchase price
|
|
—
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|||||||
|
|
$
|
85
|
|
|
$
|
266
|
|
|
$
|
31
|
|
|
$
|
315
|
|
|
$
|
11
|
|
|
$
|
35
|
|
|
$
|
743
|
|
|
Page
|
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INDEX TO FINANCIAL STATEMENT SCHEDULE
|
|
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net sales
|
|
$
|
1,182,611
|
|
|
$
|
1,095,784
|
|
|
$
|
1,149,410
|
|
Cost of products sold
|
|
767,351
|
|
|
716,067
|
|
|
746,013
|
|
|||
Gross profit
|
|
415,260
|
|
|
379,717
|
|
|
403,397
|
|
|||
Selling, administrative and engineering expenses
|
|
291,444
|
|
|
277,488
|
|
|
274,497
|
|
|||
Amortization of intangible assets
|
|
20,565
|
|
|
20,474
|
|
|
22,943
|
|
|||
Loss on product line divestiture
|
|
—
|
|
|
—
|
|
|
5,092
|
|
|||
Director & officer transition charges
|
|
—
|
|
|
7,784
|
|
|
—
|
|
|||
Restructuring charges
|
|
11,995
|
|
|
7,228
|
|
|
14,571
|
|
|||
Impairment & divestiture charges
|
|
73,058
|
|
|
116,979
|
|
|
186,511
|
|
|||
Operating profit (loss)
|
|
18,198
|
|
|
(50,236
|
)
|
|
(100,217
|
)
|
|||
Financing costs, net
|
|
31,491
|
|
|
29,703
|
|
|
28,768
|
|
|||
Other (income) expense, net
|
|
(621
|
)
|
|
2,752
|
|
|
1,359
|
|
|||
Loss before income tax expense (benefit)
|
|
(12,672
|
)
|
|
(82,691
|
)
|
|
(130,344
|
)
|
|||
Income tax expense (benefit)
|
|
8,976
|
|
|
(16,478
|
)
|
|
(25,170
|
)
|
|||
Net loss
|
|
$
|
(21,648
|
)
|
|
$
|
(66,213
|
)
|
|
$
|
(105,174
|
)
|
|
|
|
|
|
|
|
||||||
Loss per share
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
(0.36
|
)
|
|
$
|
(1.11
|
)
|
|
$
|
(1.78
|
)
|
Diluted
|
|
$
|
(0.36
|
)
|
|
$
|
(1.11
|
)
|
|
$
|
(1.78
|
)
|
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding
|
|
|
|
|
|
|
||||||
Basic
|
|
60,441
|
|
|
59,436
|
|
|
59,010
|
|
|||
Diluted
|
|
60,441
|
|
|
59,436
|
|
|
59,010
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net loss
|
|
$
|
(21,648
|
)
|
|
$
|
(66,213
|
)
|
|
$
|
(105,174
|
)
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
||||||
Foreign currency translation adjustments
|
|
49,307
|
|
|
20,470
|
|
|
(32,203
|
)
|
|||
Pension and other postretirement benefit plans
|
|
3,709
|
|
|
4,092
|
|
|
(6,003
|
)
|
|||
Cash flow hedges
|
|
—
|
|
|
—
|
|
|
23
|
|
|||
Total other comprehensive income (loss), net of tax
|
|
53,016
|
|
|
24,562
|
|
|
(38,183
|
)
|
|||
Comprehensive income (loss)
|
|
$
|
31,368
|
|
|
$
|
(41,651
|
)
|
|
$
|
(143,357
|
)
|
|
|
August 31,
|
||||||
|
|
2018
|
|
2017
|
||||
A S S E T S
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
250,490
|
|
|
$
|
229,571
|
|
Accounts receivable, net
|
|
187,749
|
|
|
190,206
|
|
||
Inventories, net
|
|
156,356
|
|
|
143,651
|
|
||
Assets held for sale
|
|
23,573
|
|
|
21,835
|
|
||
Other current assets
|
|
42,732
|
|
|
61,663
|
|
||
Total current assets
|
|
660,900
|
|
|
646,926
|
|
||
Property, plant and equipment
|
|
|
|
|
||||
Land, buildings and improvements
|
|
47,468
|
|
|
43,737
|
|
||
Machinery and equipment
|
|
229,445
|
|
|
227,535
|
|
||
Gross property, plant and equipment
|
|
276,913
|
|
|
271,272
|
|
||
Less: Accumulated depreciation
|
|
(186,693
|
)
|
|
(176,751
|
)
|
||
Property, plant and equipment, net
|
|
90,220
|
|
|
94,521
|
|
||
Goodwill
|
|
512,412
|
|
|
530,081
|
|
||
Other intangible assets, net
|
|
181,037
|
|
|
220,489
|
|
||
Other long-term assets
|
|
36,769
|
|
|
24,938
|
|
||
Total assets
|
|
$
|
1,481,338
|
|
|
$
|
1,516,955
|
|
|
|
|
|
|
||||
L I A B I L I T I E S A N D S H A R E H O L D E R S’ E Q U I T Y
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Trade accounts payable
|
|
$
|
130,838
|
|
|
$
|
133,387
|
|
Accrued compensation and benefits
|
|
54,508
|
|
|
50,939
|
|
||
Current maturities of debt
|
|
30,000
|
|
|
30,000
|
|
||
Income taxes payable
|
|
4,091
|
|
|
6,080
|
|
||
Liabilities held for sale
|
|
44,225
|
|
|
101,083
|
|
||
Other current liabilities
|
|
67,299
|
|
|
57,445
|
|
||
Total current liabilities
|
|
330,961
|
|
|
378,934
|
|
||
Long-term debt, net
|
|
502,695
|
|
|
531,940
|
|
||
Deferred income taxes
|
|
21,933
|
|
|
29,859
|
|
||
Pension and postretirement benefit liabilities
|
|
14,869
|
|
|
19,862
|
|
||
Other long-term liabilities
|
|
52,168
|
|
|
55,821
|
|
||
Total liabilities
|
|
922,626
|
|
|
1,016,416
|
|
||
Commitments and contingencies (Note 16)
|
|
|
|
|
||||
Shareholders’ equity
|
|
|
|
|
||||
Class A common stock, $0.20 par value per share, authorized 168,000,000 shares, issued 81,423,584 and 80,200,110 shares, respectively
|
|
16,285
|
|
|
16,040
|
|
||
Additional paid-in capital
|
|
167,448
|
|
|
138,449
|
|
||
Treasury stock, at cost, 20,439,434 shares
|
|
(617,731
|
)
|
|
(617,731
|
)
|
||
Retained earnings
|
|
1,166,955
|
|
|
1,191,042
|
|
||
Accumulated other comprehensive loss
|
|
(174,245
|
)
|
|
(227,261
|
)
|
||
Stock held in trust
|
|
(2,450
|
)
|
|
(2,696
|
)
|
||
Deferred compensation liability
|
|
2,450
|
|
|
2,696
|
|
||
Total shareholders’ equity
|
|
558,712
|
|
|
500,539
|
|
||
Total liabilities and shareholders’ equity
|
|
$
|
1,481,338
|
|
|
$
|
1,516,955
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Operating Activities
|
|
|
|
|
|
|
||||||
Net loss
|
|
$
|
(21,648
|
)
|
|
$
|
(66,213
|
)
|
|
$
|
(105,174
|
)
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
|
|
|
|
|
|
||||||
Non-cash items:
|
|
|
|
|
|
|
||||||
Impairment & other divestiture charges, net of tax effect
|
|
75,334
|
|
|
108,860
|
|
|
169,056
|
|
|||
Depreciation and amortization
|
|
40,707
|
|
|
43,110
|
|
|
47,777
|
|
|||
Stock-based compensation expense
|
|
14,457
|
|
|
16,733
|
|
|
10,442
|
|
|||
Benefit for deferred income taxes
|
|
(6,890
|
)
|
|
(8,956
|
)
|
|
(17,403
|
)
|
|||
Amortization of debt issuance costs
|
|
2,399
|
|
|
1,657
|
|
|
1,652
|
|
|||
Other non-cash adjustments
|
|
619
|
|
|
1,202
|
|
|
(517
|
)
|
|||
Loss on disposal of business, net of tax benefit
|
|
—
|
|
|
—
|
|
|
(1,557
|
)
|
|||
Changes in components of working capital and other, excluding acquisitions and divestitures:
|
|
|
|
|
|
|
||||||
Accounts receivable
|
|
(3,093
|
)
|
|
(3,475
|
)
|
|
20,261
|
|
|||
Inventories
|
|
(18,704
|
)
|
|
(11,277
|
)
|
|
10,202
|
|
|||
Trade accounts payable
|
|
2,593
|
|
|
18,117
|
|
|
(7,727
|
)
|
|||
Prepaid expenses and other assets
|
|
(10,625
|
)
|
|
(5,367
|
)
|
|
(3,291
|
)
|
|||
Income tax accounts
|
|
16,785
|
|
|
(10,646
|
)
|
|
(7,916
|
)
|
|||
Accrued compensation and benefits
|
|
4,827
|
|
|
3,752
|
|
|
3,912
|
|
|||
Other accrued liabilities
|
|
9,332
|
|
|
1,002
|
|
|
(2,020
|
)
|
|||
Cash provided by operating activities
|
|
106,093
|
|
|
88,499
|
|
|
117,697
|
|
|||
|
|
|
|
|
|
|
||||||
Investing Activities
|
|
|
|
|
|
|
||||||
Capital expenditures
|
|
(20,870
|
)
|
|
(28,195
|
)
|
|
(20,209
|
)
|
|||
Proceeds from sale of property, plant and equipment
|
|
153
|
|
|
570
|
|
|
9,296
|
|
|||
Rental asset buyout for Viking divestiture
|
|
(27,718
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from sale of business, net of transaction costs
|
|
8,902
|
|
|
—
|
|
|
9,695
|
|
|||
Cash paid for business acquisitions, net of cash acquired
|
|
(23,218
|
)
|
|
—
|
|
|
(81,916
|
)
|
|||
Cash used in investing activities
|
|
(62,751
|
)
|
|
(27,625
|
)
|
|
(83,134
|
)
|
|||
|
|
|
|
|
|
|
||||||
Financing Activities
|
|
|
|
|
|
|
||||||
Net repayments on revolving credit facility
|
|
—
|
|
|
—
|
|
|
(210
|
)
|
|||
Principal repayments on term loan
|
|
(30,000
|
)
|
|
(18,750
|
)
|
|
(3,750
|
)
|
|||
Redemption of 5.625% senior notes
|
|
—
|
|
|
(500
|
)
|
|
—
|
|
|||
Purchase of treasury shares
|
|
—
|
|
|
—
|
|
|
(17,101
|
)
|
|||
Taxes paid related to the net share settlement of equity awards
|
|
(1,284
|
)
|
|
(1,065
|
)
|
|
(1,409
|
)
|
|||
Stock option exercises & other
|
|
15,681
|
|
|
8,265
|
|
|
6,416
|
|
|||
Payment of deferred acquisition consideration
|
|
—
|
|
|
(742
|
)
|
|
—
|
|
|||
Cash dividend
|
|
(2,390
|
)
|
|
(2,358
|
)
|
|
(2,376
|
)
|
|||
Cash used in financing activities
|
|
(17,993
|
)
|
|
(15,150
|
)
|
|
(18,430
|
)
|
|||
Effect of exchange rate changes on cash
|
|
(4,430
|
)
|
|
4,243
|
|
|
(5,375
|
)
|
|||
Net increase in cash and cash equivalents
|
|
20,919
|
|
|
49,967
|
|
|
10,758
|
|
|||
Cash and cash equivalents - beginning of period
|
|
229,571
|
|
|
179,604
|
|
|
168,846
|
|
|||
Cash and cash equivalents - end of period
|
|
$
|
250,490
|
|
|
$
|
229,571
|
|
|
$
|
179,604
|
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Treasury
Stock
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Stock
Held in
Trust
|
|
Deferred
Compensation
Liability
|
|
Total
Shareholders’
Equity
|
|||||||||||||||||||
|
|
Issued
Shares
|
|
Amount
|
|
||||||||||||||||||||||||||||||
Balance at August 31, 2015
|
|
78,933
|
|
|
$
|
15,787
|
|
|
$
|
104,308
|
|
|
$
|
(600,630
|
)
|
|
$
|
1,367,176
|
|
|
$
|
(213,640
|
)
|
|
$
|
(4,292
|
)
|
|
$
|
4,292
|
|
|
$
|
673,001
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(105,174
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(105,174
|
)
|
||||||||
Other comprehensive loss, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(38,183
|
)
|
|
—
|
|
|
—
|
|
|
(38,183
|
)
|
||||||||
Stock contribution to employee benefit plans and other
|
|
20
|
|
|
4
|
|
|
449
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
453
|
|
||||||||
Restricted stock awards
|
|
235
|
|
|
47
|
|
|
(47
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Cash dividend ($0.04 per share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,357
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,357
|
)
|
||||||||
Treasury stock repurchases
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17,101
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17,101
|
)
|
||||||||
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
10,442
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,442
|
|
||||||||
Stock option exercises
|
|
175
|
|
|
35
|
|
|
3,529
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,564
|
|
||||||||
Tax effect of stock option exercises and restricted stock vesting
|
|
—
|
|
|
—
|
|
|
(3,943
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,943
|
)
|
||||||||
Stock issued to, acquired for and distributed from rabbi trust
|
|
30
|
|
|
6
|
|
|
242
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,646
|
|
|
(1,646
|
)
|
|
248
|
|
||||||||
Balance at August 31, 2016
|
|
79,393
|
|
|
15,879
|
|
|
114,980
|
|
|
(617,731
|
)
|
|
1,259,645
|
|
|
(251,823
|
)
|
|
(2,646
|
)
|
|
2,646
|
|
|
520,950
|
|
||||||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(66,213
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(66,213
|
)
|
||||||||
Other comprehensive income, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24,562
|
|
|
—
|
|
|
—
|
|
|
24,562
|
|
||||||||
Stock contribution to employee benefit plans and other
|
|
17
|
|
|
3
|
|
|
890
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
893
|
|
||||||||
Restricted stock awards
|
|
397
|
|
|
79
|
|
|
(79
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Cash dividend ($0.04 per share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,390
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,390
|
)
|
||||||||
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
16,733
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,733
|
|
||||||||
Stock option exercises
|
|
374
|
|
|
75
|
|
|
7,687
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,762
|
|
||||||||
Tax effect of stock option exercises and restricted stock vesting
|
|
—
|
|
|
—
|
|
|
(2,042
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,042
|
)
|
||||||||
Stock issued to, acquired for and distributed from rabbi trust
|
|
19
|
|
|
4
|
|
|
280
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(50
|
)
|
|
50
|
|
|
284
|
|
||||||||
Balance at August 31, 2017
|
|
80,200
|
|
|
16,040
|
|
|
138,449
|
|
|
(617,731
|
)
|
|
1,191,042
|
|
|
(227,261
|
)
|
|
(2,696
|
)
|
|
2,696
|
|
|
500,539
|
|
||||||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,648
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,648
|
)
|
||||||||
Other comprehensive income, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
53,016
|
|
|
—
|
|
|
—
|
|
|
53,016
|
|
||||||||
Stock contribution to employee benefit plans and other
|
|
20
|
|
|
4
|
|
|
535
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
539
|
|
||||||||
Restricted stock awards
|
|
400
|
|
|
80
|
|
|
(80
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
Cash dividend ($0.04 per share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,439
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,439
|
)
|
||||||||
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
14,457
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,457
|
|
||||||||
Stock option exercises
|
|
780
|
|
|
156
|
|
|
14,984
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,140
|
|
||||||||
Tax effect related to net share settlement of equity awards
|
|
—
|
|
|
—
|
|
|
(1,281
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,281
|
)
|
||||||||
Stock issued to, acquired for and distributed from rabbi trust
|
|
25
|
|
|
5
|
|
|
384
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
246
|
|
|
(246
|
)
|
|
389
|
|
||||||||
Balance at August 31, 2018
|
|
81,424
|
|
|
$
|
16,285
|
|
|
$
|
167,448
|
|
|
$
|
(617,731
|
)
|
|
$
|
1,166,955
|
|
|
$
|
(174,245
|
)
|
|
$
|
(2,450
|
)
|
|
$
|
2,450
|
|
|
$
|
558,712
|
|
|
|
2018
|
|
2017
|
||||
Beginning balance
|
|
$
|
6,616
|
|
|
$
|
5,592
|
|
Provision for warranties
|
|
5,522
|
|
|
5,608
|
|
||
Warranty payments and costs incurred
|
|
(7,263
|
)
|
|
(4,714
|
)
|
||
Acquisitions/divestitures
|
|
(376
|
)
|
|
—
|
|
||
Impact of changes in foreign currency rates
|
|
(82
|
)
|
|
130
|
|
||
Ending balance
|
|
$
|
4,417
|
|
|
$
|
6,616
|
|
|
|
August 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Foreign currency translation adjustments
|
|
$
|
158,497
|
|
|
$
|
207,804
|
|
Pension and other postretirement benefit plans, net
|
|
15,748
|
|
|
19,457
|
|
||
Accumulated other comprehensive loss
|
|
$
|
174,245
|
|
|
$
|
227,261
|
|
•
|
for the year-ended
August 31, 2018
, we recorded
$1.5 million
in excess tax deficiency as an increase to our income tax expense. This requirement was applied prospectively;
|
•
|
excess tax benefits are now presented as operating activities in the statement of cash flows, rather than as financing activities. The Company chose to apply this requirement retrospectively, and as a result, reclassified approximately
$0.6 million
of excess tax benefits during the year-ended
August 31, 2017
from financing activities to operating activities in the consolidated statement of cash flows;
|
•
|
our computation of diluted earnings per share now excludes the excess tax benefits or deficiencies from the assumed proceeds available to repurchase shares. This requirement was applied prospectively.
|
|
|
Year Ended August 31, 2018
|
||||||||||||||
|
|
Industrial Tools & Services
|
|
Engineered Components & Systems
|
|
Corporate
|
|
Total
|
||||||||
Balance as of August 31, 2017
|
|
$
|
1,499
|
|
|
$
|
4,108
|
|
|
$
|
30
|
|
|
$
|
5,637
|
|
Restructuring charges
|
|
4,286
|
|
|
3,713
|
|
|
4,845
|
|
|
12,844
|
|
||||
Cash payments
|
|
(3,375
|
)
|
|
(4,652
|
)
|
|
(2,357
|
)
|
|
(10,384
|
)
|
||||
Other non-cash uses of reserve
(1)
|
|
(635
|
)
|
|
(1,412
|
)
|
|
(2,103
|
)
|
|
(4,150
|
)
|
||||
Impact of changes in foreign currency rates
|
|
(88
|
)
|
|
(165
|
)
|
|
—
|
|
|
(253
|
)
|
||||
Balance as of August 31, 2018
|
|
$
|
1,687
|
|
|
$
|
1,592
|
|
|
$
|
415
|
|
|
$
|
3,694
|
|
|
|
Year Ended August 31, 2017
|
||||||||||||||
|
|
Industrial Tools & Services
|
|
Engineered Components & Systems
|
|
Corporate
|
|
Total
|
||||||||
Balance as of August 31, 2016
|
|
$
|
1,626
|
|
|
$
|
4,601
|
|
|
$
|
46
|
|
|
$
|
6,273
|
|
Restructuring charges
|
|
2,652
|
|
|
4,465
|
|
|
111
|
|
|
7,228
|
|
||||
Cash payments
|
|
(2,568
|
)
|
|
(4,858
|
)
|
|
(83
|
)
|
|
(7,509
|
)
|
||||
Other non-cash uses of reserve
|
|
(198
|
)
|
|
(285
|
)
|
|
(44
|
)
|
|
(527
|
)
|
||||
Impact of changes in foreign currency rates
|
|
(13
|
)
|
|
185
|
|
|
—
|
|
|
172
|
|
||||
Balance as of August 31, 2017
|
|
$
|
1,499
|
|
|
$
|
4,108
|
|
|
$
|
30
|
|
|
$
|
5,637
|
|
|
Total
|
||
Accounts receivable, net
|
$
|
2,324
|
|
Inventories, net
|
4,388
|
|
|
Other current assets
|
263
|
|
|
Property, plant & equipment
|
2,064
|
|
|
Goodwill
|
12,441
|
|
|
Other intangibles
|
6,049
|
|
|
Trade accounts payable
|
(2,090
|
)
|
|
Accrued compensation and benefits
|
(175
|
)
|
|
Income taxes payable
|
(779
|
)
|
|
Other current liabilities
|
(239
|
)
|
|
Deferred income taxes
|
(1,028
|
)
|
|
Cash paid for business acquisition
|
$
|
23,218
|
|
|
|
||
|
2016
|
||
Net Sales
|
|
||
As reported
|
$
|
1,149,410
|
|
Pro Forma
|
1,175,304
|
|
|
Net Loss
|
|
||
As reported
|
$
|
(105,174
|
)
|
Pro Forma
|
(100,927
|
)
|
|
Basic loss per share
|
|
||
As reported
|
$
|
(1.78
|
)
|
Pro Forma
|
(1.71
|
)
|
|
Diluted loss per share
|
|
||
As reported
|
$
|
(1.78
|
)
|
Pro Forma
|
(1.71
|
)
|
|
|
Cortland Fibron
|
|
Viking
|
||||
|
|
August 31, 2018
|
|
August 31, 2017
|
||||
Accounts receivable, net
|
|
$
|
2,924
|
|
|
$
|
2,426
|
|
Inventories, net
|
|
2,597
|
|
|
190
|
|
||
Other current assets
|
|
3,267
|
|
|
1,927
|
|
||
Property, plant & equipment, net
|
|
2,186
|
|
|
7,534
|
|
||
Goodwill and other intangible assets, net
|
|
12,464
|
|
|
—
|
|
||
Other long-term assets
|
|
135
|
|
|
9,758
|
|
||
Assets held for sale
|
|
$
|
23,573
|
|
|
$
|
21,835
|
|
|
|
|
|
|
||||
Trade accounts payable
|
|
$
|
3,915
|
|
|
$
|
1,883
|
|
Accrued compensation and benefits
|
|
1,414
|
|
|
—
|
|
||
Lease buyout accrual
|
|
—
|
|
|
28,644
|
|
||
Reserve for cumulative translation adjustment
|
|
35,346
|
|
|
68,919
|
|
||
Other current liabilities
|
|
1,269
|
|
|
1,637
|
|
||
Deferred income taxes
|
|
2,281
|
|
|
—
|
|
||
Liabilities held for sale
|
|
$
|
44,225
|
|
|
$
|
101,083
|
|
|
|
Industrial Tools & Services
|
|
Engineered Components & Systems
|
|
Total
|
||||||
Balance as of August 31, 2016
|
|
$
|
235,457
|
|
|
$
|
283,819
|
|
|
$
|
519,276
|
|
Purchase accounting adjustments
|
|
1,085
|
|
|
—
|
|
|
1,085
|
|
|||
Impact of changes in foreign currency rates
|
|
2,165
|
|
|
7,555
|
|
|
9,720
|
|
|||
Balance as of August 31, 2017
|
|
238,707
|
|
|
291,374
|
|
|
530,081
|
|
|||
Business acquisitions
|
|
12,441
|
|
|
—
|
|
|
12,441
|
|
|||
Impairment charge
|
|
—
|
|
|
(21,227
|
)
|
|
(21,227
|
)
|
|||
Impact of changes in foreign currency rates
|
|
(2,443
|
)
|
|
(4,940
|
)
|
|
(7,383
|
)
|
|||
Reclassification of assets held for sale
|
|
—
|
|
|
(1,500
|
)
|
|
(1,500
|
)
|
|||
Balance as of August 31, 2018
|
|
$
|
248,705
|
|
|
$
|
263,707
|
|
|
$
|
512,412
|
|
|
|
Weighted Average Amortization Period (Year)
|
|
August 31, 2018
|
|
August 31, 2017
|
||||||||||||||||||||
|
|
Gross
|
|
Accumulated Amortization
|
|
Net Book Value
|
|
Gross
|
|
Accumulated Amortization
|
|
Net Book Value
|
||||||||||||||
Amortizable intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Customer relationships
|
|
15
|
|
$
|
230,601
|
|
|
$
|
147,451
|
|
|
$
|
83,150
|
|
|
$
|
263,498
|
|
|
$
|
153,003
|
|
|
$
|
110,495
|
|
Patents
|
|
11
|
|
30,355
|
|
|
25,327
|
|
|
5,028
|
|
|
30,401
|
|
|
24,027
|
|
|
6,374
|
|
||||||
Trademarks and tradenames
|
|
18
|
|
20,823
|
|
|
15,347
|
|
|
5,476
|
|
|
21,498
|
|
|
9,396
|
|
|
12,102
|
|
||||||
Non-compete agreements & other
|
|
3
|
|
5,946
|
|
|
5,816
|
|
|
130
|
|
|
6,672
|
|
|
6,234
|
|
|
438
|
|
||||||
Indefinite lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Tradenames
|
|
N/A
|
|
87,253
|
|
|
—
|
|
|
87,253
|
|
|
91,080
|
|
|
—
|
|
|
91,080
|
|
||||||
|
|
|
|
$
|
374,978
|
|
|
$
|
193,941
|
|
|
$
|
181,037
|
|
|
$
|
413,149
|
|
|
$
|
192,660
|
|
|
$
|
220,489
|
|
|
Cortland
|
|
Precision-Hayes International
|
|
Total
|
||||||
Goodwill
|
$
|
3,770
|
|
|
$
|
17,457
|
|
|
$
|
21,227
|
|
Indefinite lived intangible assets
|
6,710
|
|
|
—
|
|
|
6,710
|
|
|||
Amortizable intangible assets
|
—
|
|
|
5,076
|
|
|
5,076
|
|
|||
Fixed assets
|
—
|
|
|
1,207
|
|
|
1,207
|
|
|||
|
$
|
10,480
|
|
|
$
|
23,740
|
|
|
$
|
34,220
|
|
|
Cortland
|
|
Viking
|
|
maximatecc
|
|
Total
|
||||||||
Goodwill
|
$
|
34,502
|
|
|
$
|
39,099
|
|
|
$
|
44,521
|
|
|
$
|
118,122
|
|
Indefinite lived intangible assets
|
2,211
|
|
|
13,289
|
|
|
1,153
|
|
|
16,653
|
|
||||
Amortizable intangible assets
|
—
|
|
|
27,952
|
|
|
—
|
|
|
27,952
|
|
||||
Fixed assets
|
—
|
|
|
23,784
|
|
|
—
|
|
|
23,784
|
|
||||
|
$
|
36,713
|
|
|
$
|
104,124
|
|
|
$
|
45,674
|
|
|
$
|
186,511
|
|
|
August 31,
|
||||||
|
2018
|
|
2017
|
||||
Senior Credit Facility
|
|
|
|
||||
Revolver
|
$
|
—
|
|
|
$
|
—
|
|
Term Loan
|
247,500
|
|
|
277,500
|
|
||
|
247,500
|
|
|
277,500
|
|
||
5.625% Senior Notes
|
287,559
|
|
|
287,559
|
|
||
Total Senior Indebtedness
|
535,059
|
|
|
565,059
|
|
||
Less: current maturities of long-term debt
|
(30,000
|
)
|
|
(30,000
|
)
|
||
Debt issuance costs
|
(2,364
|
)
|
|
(3,119
|
)
|
||
Total long-term debt, less current maturities
|
$
|
502,695
|
|
|
$
|
531,940
|
|
|
Year Ended August 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Foreign currency gains (losses), net
|
$
|
1,423
|
|
|
$
|
(2,962
|
)
|
|
$
|
(1,520
|
)
|
|
2018
|
|
2017
|
||||
Reconciliation of benefit obligations:
|
|
|
|
||||
Benefit obligation at beginning of year
|
$
|
46,806
|
|
|
$
|
50,409
|
|
Interest cost
|
1,633
|
|
|
1,690
|
|
||
Actuarial gain
|
(2,330
|
)
|
|
(1,997
|
)
|
||
Benefits paid
|
(2,829
|
)
|
|
(3,296
|
)
|
||
Benefit obligation at end of year
|
$
|
43,280
|
|
|
$
|
46,806
|
|
Reconciliation of plan assets:
|
|
|
|
||||
Fair value of plan assets at beginning of year
|
$
|
40,027
|
|
|
$
|
39,489
|
|
Actual return on plan assets
|
2,938
|
|
|
3,599
|
|
||
Company contributions
|
108
|
|
|
235
|
|
||
Benefits paid from plan assets
|
(2,829
|
)
|
|
(3,296
|
)
|
||
Fair value of plan assets at end of year
|
40,244
|
|
|
40,027
|
|
||
Funded status of the plans (underfunded)
|
$
|
(3,036
|
)
|
|
$
|
(6,779
|
)
|
|
Year ended August 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Interest cost
|
$
|
1,633
|
|
|
$
|
1,690
|
|
|
$
|
1,970
|
|
Expected return on assets
|
(2,668
|
)
|
|
(2,867
|
)
|
|
(2,997
|
)
|
|||
Amortization of actuarial loss
|
1,127
|
|
|
1,141
|
|
|
837
|
|
|||
Net periodic benefit expense (income)
|
$
|
92
|
|
|
$
|
(36
|
)
|
|
$
|
(190
|
)
|
|
2018
|
|
2017
|
|
2016
|
|||
Assumptions for benefit obligations:
|
|
|
|
|
|
|||
Discount rate
|
4.05
|
%
|
|
3.60
|
%
|
|
3.45
|
%
|
Assumptions for net periodic benefit cost:
|
|
|
|
|
|
|||
Discount rate
|
3.60
|
%
|
|
3.45
|
%
|
|
4.45
|
%
|
Expected return on plan assets
|
7.00
|
%
|
|
7.15
|
%
|
|
7.40
|
%
|
|
|
Year Ended August 31,
|
||||||||||||
|
|
2018
|
|
%
|
|
2017
|
|
%
|
||||||
Cash and cash equivalents
|
|
$
|
559
|
|
|
1.4
|
%
|
|
$
|
395
|
|
|
1.0
|
%
|
Fixed income securities:
|
|
|
|
|
|
|
|
|
||||||
Corporate bonds
|
|
19,107
|
|
|
47.5
|
|
|
8,475
|
|
|
21.2
|
|
||
Mutual funds
|
|
814
|
|
|
2.0
|
|
|
3,139
|
|
|
7.8
|
|
||
|
|
19,921
|
|
|
49.5
|
|
|
11,614
|
|
|
29.0
|
|
||
Equity securities:
|
|
|
|
|
|
|
|
|
||||||
Mutual funds
|
|
19,764
|
|
|
49.1
|
|
|
28,018
|
|
|
70.0
|
|
||
Total plan assets
|
|
$
|
40,244
|
|
|
100.0
|
%
|
|
$
|
40,027
|
|
|
100.0
|
%
|
|
|
August 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Benefit obligation
|
|
$
|
13,936
|
|
|
$
|
14,645
|
|
Fair value of plan assets
|
|
7,938
|
|
|
7,950
|
|
||
Funded status of plans (underfunded)
|
|
$
|
(5,998
|
)
|
|
$
|
(6,695
|
)
|
|
Year ended August 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Currently payable:
|
|
|
|
|
|
||||||
Federal
|
$
|
919
|
|
|
$
|
(14,769
|
)
|
|
$
|
2,205
|
|
Foreign
|
12,532
|
|
|
15,665
|
|
|
11,838
|
|
|||
State
|
120
|
|
|
(850
|
)
|
|
912
|
|
|||
|
13,571
|
|
|
46
|
|
|
14,955
|
|
|||
Deferred:
|
|
|
|
|
|
||||||
Federal
|
(7,837
|
)
|
|
603
|
|
|
(12,470
|
)
|
|||
Foreign
|
3,905
|
|
|
(16,837
|
)
|
|
(23,797
|
)
|
|||
State
|
(663
|
)
|
|
(290
|
)
|
|
(3,858
|
)
|
|||
|
(4,595
|
)
|
|
(16,524
|
)
|
|
(40,125
|
)
|
|||
Income tax expense (benefit)
|
$
|
8,976
|
|
|
$
|
(16,478
|
)
|
|
$
|
(25,170
|
)
|
•
|
The amount recorded for the transition tax liability is a provisional amount and based on current estimates of total post-1986 foreign E&P and the income tax pools for all foreign subsidiaries which will continue to be refined over the coming periods. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets. This amount may change when the Company finalizes the calculation of post-1986 foreign E&P previously deferred from U.S. federal taxation and finalizes the amounts held in cash or other specified assets as of August 31, 2018. Further interpretations from U.S. federal and state governments and regulatory organizations may change the provisional tax liability or the accounting treatment of the provisional tax liability. It is anticipated that the amounts resulting from the transition tax will be fully offset by available foreign tax credits and will not result in future cash tax payments. In addition, there is a foreign tax credit carryforward on the balance sheet after the calculation of the transition tax liability. The Company is continuing to analyze the new provisions in order to determine future utilization of the credits and is anticipating further interpretive guidance in connection with the utilization of foreign tax credits going forward. As such, we are not yet able to reasonably estimate the future utilization of the foreign tax credits and have recorded a corresponding valuation allowance.
|
•
|
The Company is still analyzing certain aspects of the Act and refining the estimate of the expected revaluation of its deferred tax balances. This can potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. In addition, the Act provides for accelerated first year expensing of certain capital expenditures for which an estimate has been included in the estimated deferred balances for the year but will continue to be refined through the filing of the tax return. The Act also provides changes related to the limits of deduction for employee compensation. The Company is treating any future non-deductible compensation as impacting compensation expenses in the period incurred and will review further guidance and the related impact as provided through the second quarter of fiscal 2019.
|
•
|
The Act also includes a provision designed to tax global intangible low taxed income (GILTI) and benefit foreign-derived intangible income (FDII) which will be effective in fiscal 2019. Under the provision, a U.S. shareholder is
|
•
|
Prior to the Act, our practice and intention was to reinvest the earnings in our non-U.S. subsidiaries outside of the U.S., and no U.S. deferred income taxes or foreign withholding taxes were recorded. The transition tax noted above will result in the previously untaxed foreign earnings being included in the federal and state fiscal 2018 taxable income. We are currently analyzing our global working capital requirements and the potential tax liabilities that would be incurred if the non-U.S. subsidiaries distribute cash to the U.S. parent, which may include withholding taxes, local country taxes and potential U.S. state taxation. Furthermore, the transition tax will close a majority of the outside basis differences in our foreign corporations and any remaining temporary difference will potentially have some interaction with the GILTI tax noted above. For these reasons, we are not yet able to reasonably estimate the effect of this provision of the Act and have not recorded any withholding or state tax liabilities, any deferred taxes attributable to GILTI (as noted above) or any deferred taxes attributable to our investment in our foreign subsidiaries.
|
•
|
We are also currently analyzing certain additional provisions of the Act that come into effect in fiscal 2019 and will determine if and how these items would impact the effective tax rate in the year the income or expense occurs. These provisions include the Base Erosion Anti-Abuse Tax (BEAT), eliminating U.S. federal income taxes on dividends from foreign subsidiaries, the new provision that could limit the amount of deductible interest expense, and the limitations on the deductibility of certain executive compensation.
|
|
August 31,
|
||||||
|
2018
|
|
2017
|
||||
Deferred income tax assets:
|
|
|
|
||||
Operating loss and tax credit carryforwards
|
$
|
45,947
|
|
|
$
|
41,985
|
|
Compensation related liabilities
|
10,450
|
|
|
17,319
|
|
||
Postretirement benefits
|
8,813
|
|
|
14,359
|
|
||
Inventory
|
2,081
|
|
|
2,958
|
|
||
Book reserves and other items
|
18,986
|
|
|
14,224
|
|
||
Total deferred income tax assets
|
86,277
|
|
|
90,845
|
|
||
Valuation allowance
|
(35,076
|
)
|
|
(22,671
|
)
|
||
Net deferred income tax assets
|
51,201
|
|
|
68,174
|
|
||
Deferred income tax liabilities:
|
|
|
|
||||
Depreciation and amortization
|
(48,148
|
)
|
|
(77,548
|
)
|
||
Other items
|
(633
|
)
|
|
(1,910
|
)
|
||
Deferred income tax liabilities
|
(48,781
|
)
|
|
(79,458
|
)
|
||
Net deferred income tax asset (liability)
(1)
|
$
|
2,420
|
|
|
$
|
(11,284
|
)
|
|
2018
|
|
2017
|
|
2016
|
||||||
Beginning balance
|
$
|
31,446
|
|
|
$
|
29,174
|
|
|
$
|
29,924
|
|
Increases based on tax positions related to the current year
|
2,599
|
|
|
6,057
|
|
|
1,050
|
|
|||
Increase for tax positions taken in a prior period
|
359
|
|
|
297
|
|
|
475
|
|
|||
Decrease for tax positions taken in a prior period
|
(349
|
)
|
|
(627
|
)
|
|
—
|
|
|||
Decrease due to lapse of statute of limitations
|
(9,163
|
)
|
|
(4,008
|
)
|
|
(1,027
|
)
|
|||
Decrease due to settlements
|
—
|
|
|
—
|
|
|
—
|
|
|||
Changes in foreign currency exchange rates
|
(533
|
)
|
|
553
|
|
|
(1,248
|
)
|
|||
Ending balance
|
$
|
24,359
|
|
|
$
|
31,446
|
|
|
$
|
29,174
|
|
|
Year Ended August 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Numerator:
|
|
|
|
|
|
||||||
Net loss
|
$
|
(21,648
|
)
|
|
$
|
(66,213
|
)
|
|
$
|
(105,174
|
)
|
Denominator:
|
|
|
|
|
|
||||||
Weighted average common shares outstanding - basic
|
60,441
|
|
|
59,436
|
|
|
59,010
|
|
|||
Net effect of dilutive securities - stock based compensation plans
|
—
|
|
|
—
|
|
|
—
|
|
|||
Weighted average common shares outstanding - diluted
|
60,441
|
|
|
59,436
|
|
|
59,010
|
|
|||
|
|
|
|
|
|
||||||
Basic Loss Per Share:
|
$
|
(0.36
|
)
|
|
$
|
(1.11
|
)
|
|
$
|
(1.78
|
)
|
Diluted Loss Per Share:
|
$
|
(0.36
|
)
|
|
$
|
(1.11
|
)
|
|
$
|
(1.78
|
)
|
|
|
|
|
|
|
||||||
Anti-dilutive securities- stock based compensation plans (excluding from earnings per share calculation
) (1)
|
2,923
|
|
|
4,482
|
|
|
4,832
|
|
|
Number of
Shares |
|
Weighted-Average Fair Value at Grant Date (Per Share)
|
|
Outstanding on August 31, 2017
|
1,290,448
|
|
|
$24.95
|
Granted
|
525,541
|
|
|
26.20
|
Forfeited
|
(197,771
|
)
|
|
25.05
|
Vested
|
(464,481
|
)
|
|
25.60
|
Outstanding on August 31, 2018
|
1,153,737
|
|
|
$25.25
|
|
|
Shares
|
|
Weighted-Average
Exercise Price (Per Share) |
|
Weighted-Average
Remaining Contractual Term |
|
Aggregate
Intrinsic Value |
|||||
Outstanding on September 1, 2017
|
|
3,191,630
|
|
|
$
|
24.40
|
|
|
|
|
|
||
Granted
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
Exercised
|
|
(833,377
|
)
|
|
19.96
|
|
|
|
|
|
|||
Forfeited
|
|
(119,527
|
)
|
|
23.98
|
|
|
|
|
|
|||
Expired
|
|
(469,650
|
)
|
|
28.59
|
|
|
|
|
|
|||
Outstanding on August 31, 2018
|
|
1,769,076
|
|
|
$
|
25.40
|
|
|
4.8
|
|
$
|
7.9
|
million
|
Exercisable on August 31, 2018
|
|
1,285,352
|
|
|
$
|
25.52
|
|
|
3.8
|
|
$
|
5.9
|
million
|
|
Year Ended August 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Weighted-average fair value of options granted (per share)
|
N/A
|
|
|
$
|
11.88
|
|
|
$
|
8.63
|
|
|
Intrinsic value of options exercised
|
$
|
5,284
|
|
|
2,208
|
|
|
989
|
|
||
Cash receipts from exercise of options
|
15,140
|
|
|
7,762
|
|
|
3,564
|
|
|
Fiscal Year Ended August 31,
|
||||
|
2017
|
|
2016
|
||
Dividend yield
|
0.15
|
%
|
|
0.19
|
%
|
Expected volatility
|
38.12
|
%
|
|
38.06
|
%
|
Risk-free rate of return
|
2.42
|
%
|
|
2.06
|
%
|
Expected forfeiture rate
|
11
|
%
|
|
13
|
%
|
Expected life
|
7.4 years
|
|
|
6.1 years
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net Sales by Reportable Segment & Product Line:
|
|
|
|
|
|
|
||||||
Industrial Tools & Services Segment:
|
|
|
|
|
|
|
||||||
Product
|
|
$
|
439,405
|
|
|
$
|
396,381
|
|
|
$
|
400,780
|
|
Service & Rental
|
|
151,680
|
|
|
156,201
|
|
|
187,427
|
|
|||
|
|
591,085
|
|
|
552,582
|
|
|
588,207
|
|
|||
Engineered Components & Systems Segment:
|
|
|
|
|
|
|
||||||
On-Highway
|
|
248,083
|
|
|
215,831
|
|
|
209,575
|
|
|||
Agriculture, Off-Highway and Other
|
|
215,487
|
|
|
190,604
|
|
|
187,287
|
|
|||
Rope & Cable Solutions
|
|
76,011
|
|
|
65,169
|
|
|
73,813
|
|
|||
Concrete Tensioning
|
|
49,198
|
|
|
52,889
|
|
|
50,491
|
|
|||
Off Shore Mooring
|
|
2,747
|
|
|
18,709
|
|
|
40,037
|
|
|||
|
|
591,526
|
|
|
543,202
|
|
|
561,203
|
|
|||
|
|
$
|
1,182,611
|
|
|
$
|
1,095,784
|
|
|
$
|
1,149,410
|
|
|
|
|
|
|
|
|
||||||
Operating Profit (Loss):
|
|
|
|
|
|
|
||||||
Industrial Tools & Services
|
|
$
|
99,432
|
|
|
$
|
95,825
|
|
|
$
|
119,922
|
|
Engineered Components
&
Systems
(1)
|
|
(51,982
|
)
|
|
(113,030
|
)
|
|
(190,654
|
)
|
|||
General Corporate
|
|
(29,252
|
)
|
|
(33,031
|
)
|
|
(29,485
|
)
|
|||
|
|
$
|
18,198
|
|
|
$
|
(50,236
|
)
|
|
$
|
(100,217
|
)
|
Depreciation and Amortization:
|
|
|
|
|
|
|
||||||
Industrial Tools & Services
|
|
$
|
15,301
|
|
|
$
|
15,025
|
|
|
$
|
15,173
|
|
Engineered Components & Systems
|
|
23,424
|
|
|
26,072
|
|
|
30,855
|
|
|||
General Corporate
|
|
1,982
|
|
|
2,013
|
|
|
1,749
|
|
|||
|
|
$
|
40,707
|
|
|
$
|
43,110
|
|
|
$
|
47,777
|
|
|
|
|
|
|
|
|
||||||
Capital Expenditures:
|
|
|
|
|
|
|
||||||
Industrial Tools & Services
|
|
$
|
7,799
|
|
|
$
|
8,614
|
|
|
$
|
5,502
|
|
Engineered Components & Systems
|
|
11,653
|
|
|
16,884
|
|
|
12,397
|
|
|||
General Corporate
|
|
1,418
|
|
|
2,697
|
|
|
2,310
|
|
|||
|
|
$
|
20,870
|
|
|
$
|
28,195
|
|
|
$
|
20,209
|
|
|
|
August 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Assets:
|
|
|
|
|
||||
Industrial Tools & Services
|
|
$
|
589,932
|
|
|
$
|
599,321
|
|
Engineered Components & Systems
|
|
657,370
|
|
|
713,083
|
|
||
General Corporate
|
|
234,036
|
|
|
204,551
|
|
||
|
|
$
|
1,481,338
|
|
|
$
|
1,516,955
|
|
|
|
Year Ended August 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Net Sales:
|
|
|
|
|
|
|
||||||
United States
|
|
$
|
509,952
|
|
|
$
|
480,801
|
|
|
$
|
477,670
|
|
Netherlands
|
|
166,542
|
|
|
130,724
|
|
|
143,517
|
|
|||
United Kingdom
|
|
87,182
|
|
|
84,106
|
|
|
115,183
|
|
|||
China
|
|
64,031
|
|
|
68,373
|
|
|
47,312
|
|
|||
Sweden
|
|
50,517
|
|
|
37,813
|
|
|
35,424
|
|
|||
United Arab Emirates
|
|
43,707
|
|
|
39,974
|
|
|
55,906
|
|
|||
France
|
|
40,351
|
|
|
39,563
|
|
|
42,780
|
|
|||
Australia
|
|
28,510
|
|
|
38,924
|
|
|
62,779
|
|
|||
All other
|
|
191,819
|
|
|
175,506
|
|
|
168,839
|
|
|||
|
|
$
|
1,182,611
|
|
|
$
|
1,095,784
|
|
|
$
|
1,149,410
|
|
|
|
August 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Long-lived Assets:
|
|
|
|
|
||||
United States
|
|
$
|
42,563
|
|
|
$
|
36,254
|
|
China
|
|
14,909
|
|
|
16,332
|
|
||
Netherlands
|
|
12,200
|
|
|
9,134
|
|
||
United Arab Emirates
|
|
7,876
|
|
|
8,451
|
|
||
United Kingdom
|
|
4,076
|
|
|
5,467
|
|
||
All other
|
|
20,111
|
|
|
22,696
|
|
||
|
|
$
|
101,735
|
|
|
$
|
98,334
|
|
|
|
Year Ended August 31, 2018
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Net sales
|
|
$
|
159,411
|
|
|
$
|
371,890
|
|
|
$
|
651,310
|
|
|
$
|
—
|
|
|
$
|
1,182,611
|
|
Cost of products sold
|
|
29,619
|
|
|
275,280
|
|
|
462,452
|
|
|
—
|
|
|
767,351
|
|
|||||
Gross profit
|
|
129,792
|
|
|
96,610
|
|
|
188,858
|
|
|
—
|
|
|
415,260
|
|
|||||
Selling, administrative and engineering expenses
|
|
81,194
|
|
|
72,688
|
|
|
137,562
|
|
|
—
|
|
|
291,444
|
|
|||||
Amortization of intangible assets
|
|
1,272
|
|
|
11,394
|
|
|
7,899
|
|
|
—
|
|
|
20,565
|
|
|||||
Restructuring charges
|
|
6,433
|
|
|
1,398
|
|
|
4,164
|
|
|
—
|
|
|
11,995
|
|
|||||
Impairment & divestiture charges
|
|
4,217
|
|
|
23,740
|
|
|
45,101
|
|
|
—
|
|
|
73,058
|
|
|||||
Operating profit (loss)
|
|
36,676
|
|
|
(12,610
|
)
|
|
(5,868
|
)
|
|
—
|
|
|
18,198
|
|
|||||
Financing costs (income), net
|
|
31,752
|
|
|
81
|
|
|
(342
|
)
|
|
—
|
|
|
31,491
|
|
|||||
Intercompany (income) expense, net
|
|
(17,042
|
)
|
|
26,596
|
|
|
(9,554
|
)
|
|
—
|
|
|
—
|
|
|||||
Intercompany dividends
|
|
—
|
|
|
(28,822
|
)
|
|
—
|
|
|
28,822
|
|
|
—
|
|
|||||
Other (income) expense, net
|
|
(1,200
|
)
|
|
57
|
|
|
522
|
|
|
—
|
|
|
(621
|
)
|
|||||
Earnings (loss) before income tax (benefit) expense
|
|
23,166
|
|
|
(10,522
|
)
|
|
3,506
|
|
|
(28,822
|
)
|
|
(12,672
|
)
|
|||||
Income tax (benefit) expense
|
|
(25,380
|
)
|
|
17,921
|
|
|
16,435
|
|
|
—
|
|
|
8,976
|
|
|||||
Net earnings (loss) before equity in (loss) earnings of subsidiaries
|
|
48,546
|
|
|
(28,443
|
)
|
|
(12,929
|
)
|
|
(28,822
|
)
|
|
(21,648
|
)
|
|||||
Equity in (loss) earnings of subsidiaries
|
|
(70,194
|
)
|
|
(15,652
|
)
|
|
2,103
|
|
|
83,743
|
|
|
—
|
|
|||||
Net loss
|
|
(21,648
|
)
|
|
(44,095
|
)
|
|
(10,826
|
)
|
|
54,921
|
|
|
(21,648
|
)
|
|||||
Comprehensive income (loss)
|
|
$
|
31,368
|
|
|
$
|
(44,095
|
)
|
|
$
|
40,800
|
|
|
$
|
3,295
|
|
|
$
|
31,368
|
|
|
|
Year Ended August 31, 2017
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Net sales
|
|
$
|
145,223
|
|
|
$
|
355,989
|
|
|
$
|
594,572
|
|
|
$
|
—
|
|
|
$
|
1,095,784
|
|
Cost of products sold
|
|
34,300
|
|
|
260,700
|
|
|
421,067
|
|
|
—
|
|
|
716,067
|
|
|||||
Gross profit
|
|
110,923
|
|
|
95,289
|
|
|
173,505
|
|
|
—
|
|
|
379,717
|
|
|||||
Selling, administrative and engineering expenses
|
|
74,996
|
|
|
69,826
|
|
|
132,666
|
|
|
—
|
|
|
277,488
|
|
|||||
Amortization of intangible assets
|
|
1,272
|
|
|
11,715
|
|
|
7,487
|
|
|
—
|
|
|
20,474
|
|
|||||
Director & officer transition charges
|
|
7,784
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,784
|
|
|||||
Restructuring charges
|
|
826
|
|
|
1,359
|
|
|
5,043
|
|
|
—
|
|
|
7,228
|
|
|||||
Impairment & divestiture charges
|
|
—
|
|
|
—
|
|
|
116,979
|
|
|
—
|
|
|
116,979
|
|
|||||
Operating profit (loss)
|
|
26,045
|
|
|
12,389
|
|
|
(88,670
|
)
|
|
—
|
|
|
(50,236
|
)
|
|||||
Financing costs, net
|
|
30,005
|
|
|
35
|
|
|
(337
|
)
|
|
—
|
|
|
29,703
|
|
|||||
Intercompany (income) expense, net
|
|
(22,941
|
)
|
|
22,066
|
|
|
875
|
|
|
—
|
|
|
—
|
|
|||||
Intercompany dividends
|
|
5,353
|
|
|
(59,401
|
)
|
|
(5,353
|
)
|
|
59,401
|
|
|
—
|
|
|||||
Other expense (income), net
|
|
2,690
|
|
|
87
|
|
|
(25
|
)
|
|
—
|
|
|
2,752
|
|
|||||
Earnings (loss) before income tax benefit
|
|
10,938
|
|
|
49,602
|
|
|
(83,830
|
)
|
|
(59,401
|
)
|
|
(82,691
|
)
|
|||||
Income tax benefit
|
|
(782
|
)
|
|
(14,574
|
)
|
|
(1,122
|
)
|
|
—
|
|
|
(16,478
|
)
|
|||||
Net earnings (loss) before equity in (loss) earnings of subsidiaries
|
|
11,720
|
|
|
64,176
|
|
|
(82,708
|
)
|
|
(59,401
|
)
|
|
(66,213
|
)
|
|||||
Equity in (loss) earnings of subsidiaries
|
|
(77,933
|
)
|
|
(81,389
|
)
|
|
3,335
|
|
|
155,987
|
|
|
—
|
|
|||||
Net loss
|
|
(66,213
|
)
|
|
(17,213
|
)
|
|
(79,373
|
)
|
|
96,586
|
|
|
(66,213
|
)
|
|||||
Comprehensive loss
|
|
$
|
(41,651
|
)
|
|
$
|
(35,121
|
)
|
|
$
|
(39,942
|
)
|
|
$
|
75,063
|
|
|
$
|
(41,651
|
)
|
|
|
Year Ended August 31, 2016
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Net sales
|
|
$
|
135,679
|
|
|
$
|
361,209
|
|
|
$
|
652,522
|
|
|
$
|
—
|
|
|
$
|
1,149,410
|
|
Cost of products sold
|
|
34,576
|
|
|
263,197
|
|
|
448,240
|
|
|
—
|
|
|
746,013
|
|
|||||
Gross profit
|
|
101,103
|
|
|
98,012
|
|
|
204,282
|
|
|
—
|
|
|
403,397
|
|
|||||
Selling, administrative and engineering expenses
|
|
69,677
|
|
|
69,382
|
|
|
135,438
|
|
|
—
|
|
|
274,497
|
|
|||||
Amortization of intangible assets
|
|
1,272
|
|
|
13,287
|
|
|
8,384
|
|
|
—
|
|
|
22,943
|
|
|||||
Loss on product line divestiture
|
|
—
|
|
|
5,092
|
|
|
—
|
|
|
—
|
|
|
5,092
|
|
|||||
Restructuring charges
|
|
2,426
|
|
|
3,455
|
|
|
8,690
|
|
|
—
|
|
|
14,571
|
|
|||||
Impairment charges
|
|
—
|
|
|
49,012
|
|
|
137,499
|
|
|
—
|
|
|
186,511
|
|
|||||
Operating profit (loss)
|
|
27,728
|
|
|
(42,216
|
)
|
|
(85,729
|
)
|
|
—
|
|
|
(100,217
|
)
|
|||||
Financing costs, net
|
|
30,123
|
|
|
—
|
|
|
(1,355
|
)
|
|
—
|
|
|
28,768
|
|
|||||
Intercompany (income) expense, net
|
|
(20,445
|
)
|
|
(9,999
|
)
|
|
30,444
|
|
|
—
|
|
|
—
|
|
|||||
Intercompany dividends
|
|
—
|
|
|
—
|
|
|
(5,338
|
)
|
|
5,338
|
|
|
—
|
|
|||||
Other expense, net
|
|
914
|
|
|
54
|
|
|
391
|
|
|
—
|
|
|
1,359
|
|
|||||
Earnings (loss) before income taxes
|
|
17,136
|
|
|
(32,271
|
)
|
|
(109,871
|
)
|
|
(5,338
|
)
|
|
(130,344
|
)
|
|||||
Income tax (benefit) expense
|
|
(8,729
|
)
|
|
519
|
|
|
(17,046
|
)
|
|
86
|
|
|
(25,170
|
)
|
|||||
Net earnings (loss) before equity in (loss) earnings of subsidiaries
|
|
25,865
|
|
|
(32,790
|
)
|
|
(92,825
|
)
|
|
(5,424
|
)
|
|
(105,174
|
)
|
|||||
Equity in (loss) earnings of subsidiaries
|
|
(131,037
|
)
|
|
(83,747
|
)
|
|
3,024
|
|
|
211,760
|
|
|
—
|
|
|||||
Net loss
|
|
(105,174
|
)
|
|
(116,537
|
)
|
|
(89,801
|
)
|
|
206,336
|
|
|
(105,174
|
)
|
|||||
Comprehensive loss
|
|
$
|
(143,357
|
)
|
|
$
|
(157,344
|
)
|
|
$
|
(83,802
|
)
|
|
$
|
241,146
|
|
|
$
|
(143,357
|
)
|
|
|
Year Ended August 31, 2018
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities
|
|
$
|
63,264
|
|
|
$
|
27,673
|
|
|
$
|
15,156
|
|
|
$
|
—
|
|
|
$
|
106,093
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
|
(2,822
|
)
|
|
(8,015
|
)
|
|
(10,033
|
)
|
|
—
|
|
|
(20,870
|
)
|
|||||
Proceeds from sale of property, plant and equipment
|
|
—
|
|
|
99
|
|
|
54
|
|
|
—
|
|
|
153
|
|
|||||
Rental asset buyout for Viking divestiture
|
|
—
|
|
|
—
|
|
|
(27,718
|
)
|
|
—
|
|
|
(27,718
|
)
|
|||||
Proceeds from sale of businesses, net of transaction costs
|
|
198
|
|
|
—
|
|
|
8,704
|
|
|
—
|
|
|
8,902
|
|
|||||
Cash paid for business acquisitions, net of cash acquired
|
|
—
|
|
|
(1,732
|
)
|
|
(21,486
|
)
|
|
—
|
|
|
(23,218
|
)
|
|||||
Intercompany investment
|
|
(11,754
|
)
|
|
(1
|
)
|
|
—
|
|
|
11,755
|
|
|
—
|
|
|||||
Cash used in investing activities
|
|
(14,378
|
)
|
|
(9,649
|
)
|
|
(50,479
|
)
|
|
11,755
|
|
|
(62,751
|
)
|
|||||
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Principal repayment on term loan
|
|
(30,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(30,000
|
)
|
|||||
Taxes paid related to the net share settlement of equity awards
|
|
(1,284
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,284
|
)
|
|||||
Stock option exercises, related tax benefits and other
|
|
15,681
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,681
|
|
|||||
Cash dividend
|
|
(2,390
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,390
|
)
|
|||||
Changes in receivables and payable to subsidiaries
|
|
2,041
|
|
|
(18,024
|
)
|
|
15,983
|
|
|
—
|
|
|
—
|
|
|||||
Intercompany capital contribution
|
|
—
|
|
|
—
|
|
|
11,755
|
|
|
(11,755
|
)
|
|
—
|
|
|||||
Cash (used in) provided by financing activities
|
|
(15,952
|
)
|
|
(18,024
|
)
|
|
27,738
|
|
|
(11,755
|
)
|
|
(17,993
|
)
|
|||||
Effect of exchange rate changes on cash
|
|
—
|
|
|
—
|
|
|
(4,430
|
)
|
|
—
|
|
|
(4,430
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
32,934
|
|
|
—
|
|
|
(12,015
|
)
|
|
—
|
|
|
20,919
|
|
|||||
Cash and cash equivalents—beginning of period
|
|
34,715
|
|
|
—
|
|
|
194,856
|
|
|
—
|
|
|
229,571
|
|
|||||
Cash and cash equivalents—end of period
|
|
$
|
67,649
|
|
|
$
|
—
|
|
|
$
|
182,841
|
|
|
$
|
—
|
|
|
$
|
250,490
|
|
|
|
Year Ended August 31, 2017
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities
|
|
$
|
99,241
|
|
|
$
|
14,340
|
|
|
$
|
39,672
|
|
|
$
|
(64,754
|
)
|
|
$
|
88,499
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
|
(3,391
|
)
|
|
(9,265
|
)
|
|
(15,539
|
)
|
|
—
|
|
|
(28,195
|
)
|
|||||
Proceeds from sale of property, plant and equipment
|
|
—
|
|
|
207
|
|
|
363
|
|
|
—
|
|
|
570
|
|
|||||
Intercompany investment
|
|
(6,900
|
)
|
|
—
|
|
|
—
|
|
|
6,900
|
|
|
—
|
|
|||||
Cash used in investing activities
|
|
(10,291
|
)
|
|
(9,058
|
)
|
|
(15,176
|
)
|
|
6,900
|
|
|
(27,625
|
)
|
|||||
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Principal repayment on term loan
|
|
(18,750
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(18,750
|
)
|
|||||
Redemption on 5.625% Senior Notes
|
|
(500
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(500
|
)
|
|||||
Taxes paid related to the net share settlement of equity awards
|
|
(1,065
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,065
|
)
|
|||||
Stock option exercises, related tax benefits and other
|
|
8,265
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,265
|
|
|||||
Payment of deferred acquisition consideration
|
|
—
|
|
|
—
|
|
|
(742
|
)
|
|
—
|
|
|
(742
|
)
|
|||||
Cash dividend
|
|
(2,358
|
)
|
|
(5,353
|
)
|
|
(59,401
|
)
|
|
64,754
|
|
|
(2,358
|
)
|
|||||
Intercompany loan activity
|
|
(47,780
|
)
|
|
—
|
|
|
47,780
|
|
|
—
|
|
|
—
|
|
|||||
Intercompany capital contributions
|
|
—
|
|
|
—
|
|
|
6,900
|
|
|
(6,900
|
)
|
|
—
|
|
|||||
Cash used in financing activities
|
|
(62,188
|
)
|
|
(5,353
|
)
|
|
(5,463
|
)
|
|
57,854
|
|
|
(15,150
|
)
|
|||||
Effect of exchange rate changes on cash
|
|
—
|
|
|
—
|
|
|
4,243
|
|
|
—
|
|
|
4,243
|
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
26,762
|
|
|
(71
|
)
|
|
23,276
|
|
|
—
|
|
|
49,967
|
|
|||||
Cash and cash equivalents—beginning of period
|
|
7,953
|
|
|
71
|
|
|
171,580
|
|
|
—
|
|
|
179,604
|
|
|||||
Cash and cash equivalents—end of period
|
|
$
|
34,715
|
|
|
$
|
—
|
|
|
$
|
194,856
|
|
|
$
|
—
|
|
|
$
|
229,571
|
|
|
|
Year Ended August 31, 2016
|
||||||||||||||||||
|
|
Parent
|
|
Guarantors
|
|
Non-Guarantors
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash provided by (used in) operating activities
|
|
$
|
58,926
|
|
|
$
|
(1,953
|
)
|
|
$
|
66,062
|
|
|
$
|
(5,338
|
)
|
|
$
|
117,697
|
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Capital expenditures
|
|
(2,135
|
)
|
|
(6,781
|
)
|
|
(11,293
|
)
|
|
—
|
|
|
(20,209
|
)
|
|||||
Proceeds from sale of property, plant and equipment
|
|
13
|
|
|
7,000
|
|
|
2,283
|
|
|
—
|
|
|
9,296
|
|
|||||
Intercompany investment
|
|
(339
|
)
|
|
(3,458
|
)
|
|
—
|
|
|
3,797
|
|
|
—
|
|
|||||
Business acquisitions, net of cash acquired
|
|
—
|
|
|
—
|
|
|
(81,916
|
)
|
|
—
|
|
|
(81,916
|
)
|
|||||
Proceeds from sale of businesses, net of transaction costs
|
|
—
|
|
|
9,695
|
|
|
—
|
|
|
—
|
|
|
9,695
|
|
|||||
Cash (used in) provided by investing activities
|
|
(2,461
|
)
|
|
6,456
|
|
|
(90,926
|
)
|
|
3,797
|
|
|
(83,134
|
)
|
|||||
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net repayments on revolving credit facility
|
|
—
|
|
|
—
|
|
|
(210
|
)
|
|
—
|
|
|
(210
|
)
|
|||||
Principal repayments on term loan
|
|
(3,750
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,750
|
)
|
|||||
Purchase of treasury shares
|
|
(17,101
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17,101
|
)
|
|||||
Taxes paid related to the net share settlement of equity awards
|
|
(1,409
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,409
|
)
|
|||||
Stock option exercises, related tax benefits and other
|
|
6,416
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,416
|
|
|||||
Cash dividend
|
|
(2,376
|
)
|
|
(5,338
|
)
|
|
—
|
|
|
5,338
|
|
|
(2,376
|
)
|
|||||
Intercompany loan activity
|
|
(48,980
|
)
|
|
—
|
|
|
48,980
|
|
|
—
|
|
|
—
|
|
|||||
Intercompany capital contributions
|
|
—
|
|
|
339
|
|
|
3,458
|
|
|
(3,797
|
)
|
|
—
|
|
|||||
Cash (used in) provided by financing activities
|
|
(67,200
|
)
|
|
(4,999
|
)
|
|
52,228
|
|
|
1,541
|
|
|
(18,430
|
)
|
|||||
Effect of exchange rate changes on cash
|
|
—
|
|
|
—
|
|
|
(5,375
|
)
|
|
—
|
|
|
(5,375
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
(10,735
|
)
|
|
(496
|
)
|
|
21,989
|
|
|
—
|
|
|
10,758
|
|
|||||
Cash and cash equivalents—beginning of period
|
|
18,688
|
|
|
567
|
|
|
149,591
|
|
|
—
|
|
|
168,846
|
|
|||||
Cash and cash equivalents—end of period
|
|
$
|
7,953
|
|
|
$
|
71
|
|
|
$
|
171,580
|
|
|
$
|
—
|
|
|
$
|
179,604
|
|
|
|
Year Ended August 31, 2018
|
||||||||||||||||||
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Total
|
||||||||||
Net sales
|
|
$
|
288,955
|
|
|
$
|
275,165
|
|
|
$
|
317,096
|
|
|
$
|
301,395
|
|
|
$
|
1,182,611
|
|
Gross profit
|
|
100,911
|
|
|
89,696
|
|
|
116,509
|
|
|
108,144
|
|
|
415,260
|
|
|||||
Net earnings (loss)
|
|
5,226
|
|
|
(18,221
|
)
|
|
29,012
|
|
|
(37,665
|
)
|
|
(21,648
|
)
|
|||||
Net earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
|
$
|
0.09
|
|
|
$
|
(0.30
|
)
|
|
$
|
0.48
|
|
|
$
|
(0.62
|
)
|
|
$
|
(0.36
|
)
|
Diluted
|
|
$
|
0.09
|
|
|
$
|
(0.30
|
)
|
|
$
|
0.48
|
|
|
$
|
(0.62
|
)
|
|
$
|
(0.36
|
)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
Year Ended August 31, 2017
|
||||||||||||||||||
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
|
Total
|
||||||||||
Net sales
|
|
$
|
265,793
|
|
|
$
|
258,869
|
|
|
$
|
295,427
|
|
|
$
|
275,695
|
|
|
$
|
1,095,784
|
|
Gross profit
|
|
93,067
|
|
|
87,327
|
|
|
102,804
|
|
|
96,519
|
|
|
379,717
|
|
|||||
Net earnings (loss)
|
|
4,966
|
|
|
5,074
|
|
|
22,511
|
|
|
(98,764
|
)
|
|
(66,213
|
)
|
|||||
Net earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
|
$
|
0.08
|
|
|
$
|
0.09
|
|
|
$
|
0.38
|
|
|
$
|
(1.65
|
)
|
|
$
|
(1.11
|
)
|
Diluted
|
|
$
|
0.08
|
|
|
$
|
0.08
|
|
|
$
|
0.37
|
|
|
$
|
(1.65
|
)
|
|
$
|
(1.11
|
)
|
|
|
|
|
Additions
|
|
Deductions
|
|
|
|
|
||||||||||||||
|
|
Balance at
Beginning of Period |
|
Charged to
Costs and Expenses |
|
Acquisition/ (Divestiture)
|
|
Accounts
Written Off Less Recoveries |
|
Other
|
|
Balance at
End of Period |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Allowance for losses—Trade accounts receivable
|
|
|
|
|
|
|
|
|
||||||||||||||||
August 31, 2018
|
|
$
|
11,229
|
|
|
$
|
1,389
|
|
|
$
|
76
|
|
|
$
|
(6,856
|
)
|
|
$
|
(437
|
)
|
|
$
|
5,401
|
|
August 31, 2017
|
|
7,762
|
|
|
3,112
|
|
|
1,452
|
|
|
(1,422
|
)
|
|
325
|
|
|
11,229
|
|
||||||
August 31, 2016
|
|
3,970
|
|
|
2,274
|
|
|
3,090
|
|
|
(1,580
|
)
|
|
8
|
|
|
7,762
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Valuation allowance—Income taxes
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
August 31, 2018
|
|
$
|
22,671
|
|
|
$
|
25,209
|
|
|
$
|
—
|
|
|
$
|
(12,804
|
)
|
|
$
|
—
|
|
|
$
|
35,076
|
|
August 31, 2017
|
|
8,147
|
|
|
15,144
|
|
|
—
|
|
|
(620
|
)
|
|
—
|
|
|
22,671
|
|
||||||
August 31, 2016
|
|
8,053
|
|
|
852
|
|
|
—
|
|
|
(1,026
|
)
|
|
268
|
|
|
8,147
|
|
|
A
CTUANT
C
ORPORATION
(Registrant)
|
|
|
|
|
|
By:
|
/
S
/ RICK T. DILLON
|
|
|
Rick T. Dillon
|
|
|
Executive Vice President and Chief
Financial Officer
|
|
|
(Principal Financial Officer)
|
Signature
|
|
Title
|
|
|
|
/s/ RANDAL W. BAKER
|
|
President and Chief Executive Officer, Director
|
Randal W. Baker
|
|
|
|
|
|
/s/ ALFREDO ALTAVILLA
|
|
Director
|
Alfredo Altavilla
|
|
|
|
|
|
/s/ J. PALMER CLARKSON
|
|
Director
|
J. Palmer Clarkson
|
|
|
|
|
|
/s/ DANNY L. CUNNINGHAM
|
|
Director
|
Danny L. Cunningham
|
|
|
|
|
|
/s/ E. JAMES FERLAND
|
|
Director
|
E. James Ferland
|
|
|
|
|
|
/s/ RICHARD D. HOLDER
|
|
Director
|
Richard D. Holder
|
|
|
|
|
|
/s/ ROBERT A. PETERSON
|
|
Chairman of the Board of Directors
|
Robert A. Peterson
|
|
|
|
|
|
/s/ SIDNEY S. SIMMONS
|
|
Director
|
Sidney S. Simmons
|
|
|
|
|
|
/s/ HOLLY A. VAN DEURSEN
|
|
Director
|
Holly A. Van Deursen
|
|
|
|
|
|
/s/ RICK T. DILLON
|
|
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
Rick T. Dillon
|
|
|
|
|
|
/s/ BRYAN R. JOHNSON
|
|
Corporate Controller and Principal Accounting Officer
|
Bryan R. Johnson
|
|
|
Exhibit
|
|
Description
|
|
Incorporated Herein By Reference To
|
|
Filed
Herewith
|
|
Furnished Herewith
|
|
3.1
|
|
|
|
Exhibit 4.9 to the Registrant's Form 10-Q for the quarter ended February 28, 2001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3.1(b) of the Registrant's Form 10-K for the fiscal year ended August 31, 2003
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3.1 to the Registrant's Form 10-K for the fiscal year ended August 31, 2004
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3.1 to the Registrant's Form 8-K filed on July 18, 2006
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3.1 to the Registrant's Form 8-K filed on January 14, 2010
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Amended and Restated Bylaws, as amended
|
|
Exhibit 3.1 of the Registrant's Form 8-K filed on July 23, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indenture dated April 16, 2012 by and among Actuant Corporation, the subsidiary guarantors named therein and U.S. Bank National Association as trustee relating to $300 million Actuant Corporation 5
5
/
8
% Senior Notes due 2022
|
|
Exhibit 4.1 to the Registrant's Current Report on Form 8-K filed on April 18, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fifth Amended and Restated Credit Agreement dated May 8, 2015 among Actuant Corporation, the Lenders party thereto and JP Morgan Chase, N.A. as the agent
|
|
Exhibit 10.1 to the Registrant's Form 10-Q for the quarter ended May 31, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amendment No. 1 to the Fifth Amended and Restated Credit Agreement dated June 20, 2017 among Actuant Corporation, the Lenders party thereto and JP Morgan Chase, N.A. as the agent
|
|
Exhibit 4.2(b) to the Registrant’s Form 10-Q for the quarter ended May 31, 2017
|
|
|
|
|
Exhibit
|
|
Description
|
|
Incorporated Herein By Reference To
|
|
Filed
Herewith |
|
Furnished Herewith
|
|
|
|
Outside Directors’ Deferred Compensation Plan (conformed through the second amendment)
|
|
Exhibit 10.1 to the Registrant's Form 10-Q for the quarter ended November 30, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuant Corporation Deferred Compensation Plan (conformed through the fourth amendment)
|
|
Exhibit 10.2 to the Registrant's Form 10-Q for the quarter ended November 30, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuant Corporation 2010 Employee Stock Purchase Plan
|
|
Exhibit B to the Registrant's Definitive Proxy Statement, dated December 4, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Actuant Corporation 2017 Omnibus Incentive Plan
|
|
Exhibit A to the Registrant's Definitive Proxy Statement dated December 5, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit A to the Registrant's Definitive Proxy Statement dated December 4, 2017
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Actuant Corporation 2009 Omnibus Incentive Plan, conformed through the Second Amendment thereto
|
|
Exhibit 99.1 to the Registrant's Form 8-K filed on January 17, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.6
|
|
|
|
Exhibit A to the Registrant's Definitive Proxy Statement, dated December 5, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.10 to the Registrant's Form 10-Q for the quarter ended November 30, 2008
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Actuant Corporation Supplemental Executive Retirement Plan (conformed through the first amendment)
|
|
Exhibit 10.3 to the Registrant's Form 10-Q for the quarter ended November 30, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Form of Indemnification Agreement for Directors and Officers
|
|
Exhibit 10.1 to the Registrant's Form 8-K filed on August 2, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Form of Amended and Restated Actuant Corporation Change in Control Agreement
|
|
Exhibit 10.1 to the Registrant’s Form 8-K filed on August 1, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuant Corporation Executive Officer Bonus Plan
|
|
Exhibit B to the Registrant's Definitive Proxy Statement dated December 3, 2012
|
|
|
|
|
Exhibit
|
|
Description
|
|
Incorporated Herein By Reference To
|
|
Filed
Herewith |
|
Furnished Herewith
|
|
10.11
|
|
|
|
Exhibit 10.1(a) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.1(b) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
10.12
|
|
|
|
Exhibit 10.2(a) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.2(b) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
10.13
|
|
|
|
Exhibit 10.3(a) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.3(b) to the Registrant's Form 10-Q for the quarter ended February 28, 2014
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
(a) Form RSA Award (Director) under Actuant Corporation 2017 Omnibus Incentive Plan
|
|
|
|
X
|
|
|
||
|
|
|
|
|
|
|
|
|
|
10.15
|
|
|
|
|
X
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
||
|
|
|
|
|
|
|
|
|
|
10.16
|
|
|
|
|
X
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
Exhibit
|
|
Description
|
|
Incorporated Herein By Reference To
|
|
Filed
Herewith |
|
Furnished Herewith
|
|
|
|
Offer letter dated February 24, 2016 between Actuant Corporation and Randal W. Baker
|
|
Exhibit 10.1 to the Registrant's Form 8-K filed on March 1, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separation and Release Agreement dated September 7, 2016 by and between Actuant Corporation and David (Mark) Sefcik
|
|
Exhibit 10.16 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Agreement by and between Actuant Corporation and Eugene E. Skogg
|
|
Exhibit 10.17 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offer Letter by and between Actuant Corporation and Rick T. Dillon
|
|
Exhibit 10.1 to Registrant's Form 8-K filed on November 18, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separation Agreement and Release by and between Actuant Corporation and Andrew G. Lampereur
|
|
Exhibit 10.4 to Registrant's Form 8-K filed on November 18, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separation and Release Agreement dated October 9, 2017 by and between Actuant Corporation and Eugene E. Skogg
|
|
Exhibit 10.21 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separation and Release Agreement dated October 6, 2017 by and between Actuant Corporation and Stephen J. Rennie
|
|
Exhibit 10.22 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offer Letter by and between Actuant Corporation and Andre L. Williams dated September 11, 2017
|
|
Exhibit 10.23 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Separation and Release Agreement dated October 26, 2017 by and between Actuant Corporation and Theodore C. Wozniak
|
|
Exhibit 10.24 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agreement by and between Actuant Corporation and Southeastern Capital Management dated March 20, 2018
|
|
Exhibit 10.1 of Registrant's Form 8-K filed on March 21, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offer letter by and between Actuant Corporation and John Jeffery Schmaling dated January 18, 2018
|
|
Exhibit 10.3 of the Registrant's Form 10-Q for the quarter ended February 28, 2018.
|
|
|
|
|
Exhibit
|
|
Description
|
|
Incorporated Herein By Reference To
|
|
Filed
Herewith |
|
Furnished Herewith
|
|
|
|
Offer letter by and between Actuant Corporation and Fabrizio R. Rasetti dated April 12, 2018
|
|
Exhibit 10.1 of the Registrant's Form 10-Q for the quarter ended May 31, 2018.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Code of Ethics Applicable to Senior Financial Executives
|
|
Exhibit 14 of the Registrant’s Form 10-K for the fiscal year ended August 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiaries of the Registrant
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consent of PricewaterhouseCoopers LLP
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Power of Attorney
|
|
|
|
See signature page of this report
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following materials from the Actuant Corporation Form 10-K for the year ended August 31, 2018 formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to Consolidated Financial Statements.
|
|
|
|
X
|
|
|
Months from Date of Grant
|
|
Vested Percentage of RSUs Awarded
|
After 11 Months
|
|
100%
|
Years from Date of Grant
|
|
Vested Percentage of RSUs Awarded
|
After 11 Months
|
|
100%
|
Years from Date of Grant
|
|
Cumulative
Vested Percentage of RSUs Awarded
|
After One Year
|
|
33.3%
|
After Two Years
|
|
66.6%
|
After Three Years
|
|
100.0%
|
1.
|
Incorporation or recitals
. The above recitals are incorporated herein as part of the Agreement.
|
2.
|
Definitions
. Unless otherwise defined herein, the capitalized terms set forth in this Agreement shall have the definitions as set forth in Attachment A. Attachment A is incorporated into and is part of this Agreement.
|
3.
|
Duty of Loyalty
. Grantee acknowledges that Grantee is a key employee of the Company and owes the Company a fiduciary duty of loyalty. During employment with Company, Grantee shall owe Company an undivided duty of loyalty, and shall take no action adverse to that duty of loyalty. Grantee’s duty of loyalty to Company includes but is not limited to a duty to promptly disclose to Company any information that might cause Company to take or refrain from taking any action, or which otherwise might cause Company to alter its behavior. Without limiting the generality of the foregoing, Grantee shall promptly notify Company at any time that Grantee decides to terminate employment with Company or enter into competition with Company, as Company may decide at such time to limit, suspend, or terminate Grantee’s employment or access to Company’s Confidential Information, Trade Secrets, and/or customer relationships. Grantee’s privilege to access and use Company’s computers, and to access and use Company’s electronically stored information including Company’s Confidential Information and Trade Secrets, are revoked the moment Grantee takes any action adverse to Grantee’s duty of loyalty to Company.
|
4.
|
Nondisclosure of Third Party Confidential Information
. During Grantee’s employment with Company and after the Termination Date, Grantee shall not use or disclose Third Party Confidential Information for as long as the relevant third party has required Company to maintain its confidentiality, or for so long as required by applicable law, whichever period is longer.
|
5.
|
Non-disclosure of Trade Secrets
. During employment and after the Termination Date, Grantee shall not use or disclose Company’s Trade Secrets so long as they remain Trade Secrets. Nothing in this Agreement shall limit either Grantee’s statutory or other duties not to use or disclose Company’s Trade Secrets, or Company’s remedies in the event Grantee uses or discloses Company’s Trade Secrets.
|
6.
|
Obligations Not to Disclose or Use Confidential Information
. Except as set forth herein or as expressly authorized in writing on behalf of Company, Grantee agrees that while Grantee is employed by Company and during the twelve (12)
|
7.
|
Return of Property; No Copying or Transfer of Documents
. All equipment, books, records, papers, notes, catalogs, compilations of information, data bases, correspondence, recordings, stored data (including but not limited to data or files that exist on any personal computer or other electronic storage device), software, and any physical items, including copies and duplicates, that Grantee generates or develops or which come into Grantee’s possession or control, which relate directly or indirectly to, or are a part of Company’s (or its customers’) business matters, whether of a public nature or not (collectively “Company Records”), shall be and remain the property of Company, and Grantee shall deliver all such materials and items, and any and all copies of them, to Company upon termination of employment. During employment or after Termination Date, Grantee will not copy, duplicate, or otherwise reproduce, or permit copying, duplicating, or reproduction of Company Records without the express written consent of Company, or, as a part of Grantee’s duties performed hereunder for the benefit of Company. Grantee expressly covenants and warrants, upon termination of employment for any reason (or no reason), that Grantee shall promptly deliver to Company any and all originals and copies of Company Records in Grantee’s possession, custody, or control, and that Grantee shall not make, retain, or transfer to any third party any copies thereof. In the event any Confidential Information or Trade Secrets are stored or otherwise kept in or on a computer hard drive or other storage device owned by or otherwise in the possession or control of Grantee (each individually an "Grantee Storage Device"), upon termination of employment Grantee will present every such Grantee Storage Device to Company for inspection and removal of all information regarding Company or its customers (including but not limited to Confidential Information or Trade Secrets) that is stored on the Grantee Storage Device. This Paragraph shall not bar Grantee from retaining Grantee’s own payroll, retirement, insurance, tax, and other personnel documents related to Company.
|
8.
|
Covenants Barring Certain Unfair Activities
. Grantee shall abide by such restrictions in Attachment B hereto. Attachment B is incorporated into and is part of this Agreement.
|
(a)
|
Non-solicitation of Management Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Management Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Management Employee has already ceased employment with Company.
|
(b)
|
Non-solicitation of Key Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Key Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Key Employee has already ceased employment with Company.
|
(c)
|
Non-solicitation of Supervised Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Supervised Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Supervised Employee has already ceased employment with Company.
|
10.
|
Proprietary Creations
. All Proprietary Creations are the sole and exclusive property of the Company whether patentable or registrable or not, and Grantee assigns all of Grantee’s rights, title, and interest in same to the Company. Further, all Proprietary Creations which are copyrightable shall be considered “work(s) made for hire” as that term is defined by U.S. Copyright Law. If for any reason a U.S. Court of competent jurisdiction determines such Proprietary
|
11.
|
Remedies
. In addition to other remedies provided by law or equity, the Parties agree that in the event of any breach or threatened breach of this Agreement, Company may obtain interim or other injunctive relief, in addition to any other remedies available, without the need to post a bond. Grantee further agrees that any breach of this Agreement would result in irreparable harm to Company entitling Company to an injunction prohibiting further breaches of these Paragraphs. The Parties agree that in the event Grantee breaches this Agreement, Grantee shall pay the Company’s reasonable attorney’s fees and costs arising out of any litigation resulting from Grantee’s breach.
|
12.
|
Assignmen
t. Company may assign its rights under the Agreement to any assignee or successor. Such assignment shall not require the authorization of Grantee. Grantee may not assign or delegate Grantee’s rights or obligations under this Agreement.
|
13.
|
Entire Agreement
. This Agreement constitutes the entire agreement and understanding between Company and Grantee concerning the subject matter addressed herein and supersedes and extinguishes any and all other or previous discussions, agreements, or understandings between the Parties regarding the subject matter herein. Notwithstanding this Paragraph 13, this Agreement shall not serve to supersede or extinguish other agreements between Grantee and Company (and their subsidiary or affiliated companies and successors) containing similar provisions and restrictions where such agreements were entered into with Grantee as a term or condition of employment.
|
14.
|
Waiver.
The waiver by any Party of the breach of any covenant or provision in this Agreement shall not operate or be construed as a waiver of any subsequent breach by any Party.
|
15.
|
Invalidity of any Provision
. The provisions of this Agreement are severable, it being the intention of the Parties that should any provision hereof be invalid or unenforceable, such invalidity or unenforceability of any provision shall not affect the remaining provisions hereof, but the same shall remain in full force and effect to the fullest extent permitted by law as if such invalid or unenforceable provision were omitted. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, Company and Grantee agree that such provision is to be reformed to the extent necessary for the provision to be valid and enforceable to the fullest and broadest extent permitted by applicable law, without invalidating the remainder of this Agreement
|
16.
|
Applicable Law and Venue
. The Parties agree that this Agreement shall be governed by and construed in accordance with the internal laws of the State of Wisconsin. Any dispute between the Parties arising out of or related to the terms of this Agreement shall be heard only by the Circuit Court of Waukesha County, Wisconsin, or by the United States District Court for the Eastern District of Wisconsin; and the Parties hereby consent to these courts as the exclusive venues for resolving any such disputes.
|
17.
|
Headings.
Headings in this Agreement are for informational purposes only and shall not be used to construe the intent of this Agreement.
|
18.
|
Counterparts
. This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same agreement.
|
19.
|
Reserved Rights
. Nothing in this Agreement shall serve to limit or restrict Grantee’s right to the following:
|
(a)
|
Immunity
. An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (i) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(b)
|
Use Of Trade Secret Information In Anti-Retaliation Lawsuit
. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (i) files any document containing the trade secret under seal; and (ii) does not disclose the trade secret, except pursuant to court order.
|
20.
|
Reasonableness of Restrictions
. GRANTEE HAS READ THIS AGREEMENT AND AGREES THAT THE RESTRICTIONS ON GRANTEE’S ACTIVITIES OUTLINED IN THIS AGREEMENT ARE REASONABLE AND NECESSARY TO PROTECT COMPANY’S LEGITIMATE BUSINESS INTERESTS, THAT THE CONSIDERATION PROVIDED BY COMPANY IS FAIR AND REASONABLE, AND FURTHER AGREES THAT GIVEN THE IMPORTANCE TO COMPANY OF ITS CONFIDENTIAL INFORMATION, TRADE SECRETS, AND CUSTOMER RELATIONSHIPS, THE POST-EMPLOYMENT RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE. GRANTEE AGREES THAT THE GEOGRAPHIC RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE REASONABLE.
|
(a)
|
“
Competing Product
” means any product or service which is sold or provided in competition with a product or service produced, designed, sold or provided by Grantee, either individually or as part of a team, or by one or more employees or Company business units managed, supervised or directed by Grantee or receiving executive or management support from Grantee during the twelve (12) months immediately preceding the Termination Date.
|
(b)
|
“
Confidential Information
” means information (to the extent it is not a Trade Secret), whether oral, written, recorded magnetically or electronically, or otherwise stored, and whether originated by the Grantee or otherwise coming into the possession or knowledge of the Grantee, which is possessed by or developed for Company, and which relates to Company’s existing or potential business, which information is not reasonably ascertainable by Company’s competitors or by the general public through lawful means, and which information Company treats as confidential, including but not limited to information regarding Company’s business affairs, RSU Agreements, strategies, products, finances, costs, margins, computer programs, research, customers, purchasing, marketing, and other information.
|
(c)
|
“
Current Pending Customer
” means a person or entity concerning which Company is actively preparing a business proposal to a prospective customer of the Company as of the Termination Date, or for which Company has a pending proposal to provide goods or services as a Company to a prospect customer as of the Termination Date. However, the term “Current Pending Customer” is limited to persons or entities that Grantee interacts with on behalf of the Company or concerning which Grantee learns, creates or reviews Confidential Information or Trade Secrets on behalf of the Company in the three (3) month period immediately preceding the Grantee’s end of employment with the Company.
|
(d)
|
“
Key Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person is in possession of Confidential Information and/or Trade Secrets.
|
(e)
|
“
Key Services
” means services of the type performed by a Management Employee, Key Employee or Supervised Employee for the Company during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(f)
|
“
Management Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date and such person is a manager, officer, director, or executive of Company.
|
(g)
|
“
Proprietary Creations
” means all inventions, discoveries, designs, improvements, creations, and works conceived, authored, or developed by Grantee, either individually or with others, any time during Grantee’s employment with the Company that: (1) relate to the Company’s current or contemplated business or activities; (2) relate to the Company’s actual or demonstrably anticipated research or development; (3) result from any work performed by Grantee for the Company; (4) involve the use of Company equipment, supplies, facilities, Confidential Information or Trade Secrets; (5) result from or are suggested by any work done by the Company or at the Company’s request, or any projects specifically assigned to Grantee; or (6) result from Grantee’s access to any Company memoranda, notes, records, drawings, sketches, models, maps, customer lists, research results, data, formulae, specifications, inventions, processes, equipment Confidential Information, Trade Secrets or other materials.
|
(h)
|
“
Referral Client
” means a person or entity that does not directly purchase products or services from Company, but which has the ability to effectively specify or recommend the purchase of products or services from Company or its competitors to end customers. The term Referral Client is limited to persons or entities to or through which Grantee, one or more individuals or Company business units supervised, managed or directed by Grantee, markets or sells Company products or services during the twelve (12) month period immediately preceding the Termination Date. The term Referral Client is further restricted to persons or entities which have specified or recommended the purchase of in excess of fifty thousand dollars (US $50,000) worth of products or services
|
(i)
|
“
Restricted Customer
” means a customer of Company to which Grantee, or one or more individuals or Company business units supervised, managed, or directed by Grantee, sells or provides products or services on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Restricted Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(j)
|
“
Restricted Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, Grantee, or one or more other Company employees or Company business units supervised, managed or directed by or receiving management or executive support from Grantee: (i) provides products or services on behalf of the Company; or (ii) sells or solicits the sale of products or services on behalf of the Company. Notwithstanding the foregoing, the term Restricted Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(k)
|
“
Sales Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, the Company: (i) sells products or services designed, developed, tested, or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee; or (ii) provides products or services designed, developed, tested or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee. Notwithstanding the foregoing, the term Sales Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(l)
|
“
Services
” means services of the type performed for Company by Grantee or one or more Company employees managed, supervised, or directed by Grantee during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(m)
|
“
Strategic Customer
” means a customer of Company that purchases or receives a product or service from Company during the twelve (12) month period immediately preceding the Termination Date, but is limited to customers concerning which Grantee learns, creates, or reviews Confidential Information or Trade Secrets on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Strategic Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(n)
|
“
Supervised Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person was directly managed by or reported to Grantee during the last 12 months prior to the Termination Date.
|
(o)
|
“
Termination Date
” means the last date that Grantee serves as an employee of the Company.
|
(p)
|
“
Third Party Confidential Information
” means information received by Company from others that Company has an obligation to treat as confidential.
|
(q)
|
“
Trade Secret
” means a Trade Secret as that term is defined under applicable state or federal law.
|
(r)
|
“
Territory
” means a county within the United States of America, or a city, town or other municipality within a foreign nation.
|
1.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
2.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling, or soliciting the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
3.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Restricted Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
4.
|
For twelve (12) months following Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
5.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
6.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Strategic Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
7.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
8.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
9.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Referral Client to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
10.
|
For three (3) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Current Pending Customer or assist others in doing so.
|
11.
|
For twelve (12) months following Termination Date, Grantee shall not accept a position or provide services to a competitor in any capacity in which it is reasonably likely that Grantee would inevitably use or disclose the Company’s Confidential Information or Trade Secrets. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor.
|
12.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Restricted Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in sales, sales management, or served as an executive or officer of the Company.
|
13.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing, or producing Competing Products for sale in the Restricted Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
14.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Sales Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
15.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing or producing Competing Products for sale in the Sales Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
Performance Objective
|
Minimum
|
Target
|
Maximum
|
TSR Percentile Performance
|
25
th
Percentile
|
50
th
Percentile
|
75
th
Percentile
|
Performance Shares Earned
|
50%
|
100%
|
150%
|
a.
|
as a result of death
|
b.
|
as a result of total and permanent disability, as determined by the Committee in its sole and complete discretion, or
|
c.
|
with respect to a Grantee who has been employed by the Company for at least eight years, as a result of retirement on or after Grantee attaining age 60,
|
1.
|
Incorporation or recitals
. The above recitals are incorporated herein as part of the Agreement.
|
2.
|
Definitions
. Unless otherwise defined herein, the capitalized terms set forth in this Agreement shall have the definitions as set forth in Attachment A. Attachment A is incorporated into and is part of this Agreement.
|
3.
|
Duty of Loyalty
. Grantee acknowledges that Grantee is a key employee of the Company and owes the Company a fiduciary duty of loyalty. During employment with Company, Grantee shall owe Company an undivided duty of loyalty, and shall take no action adverse to that duty of loyalty. Grantee’s duty of loyalty to Company includes but is not limited to a duty to promptly disclose to Company any information that might cause Company to take or refrain from taking any action, or which otherwise might cause Company to alter its behavior. Without limiting the generality of the foregoing, Grantee shall promptly notify Company at any time that Grantee decides to terminate employment with Company or enter into competition with Company, as Company may decide at such time to limit, suspend, or terminate Grantee’s employment or access to Company’s Confidential Information, Trade Secrets, and/or customer relationships. Grantee’s privilege to access and use Company’s computers, and to access and use Company’s electronically stored information including Company’s Confidential Information and Trade Secrets, are revoked the moment Grantee takes any action adverse to Grantee’s duty of loyalty to Company.
|
4.
|
Nondisclosure of Third Party Confidential Information
. During Grantee’s employment with Company and after the Termination Date, Grantee shall not use or disclose Third Party Confidential Information for as long as the relevant third party has required Company to maintain its confidentiality, or for so long as required by applicable law, whichever period is longer.
|
5.
|
Non-disclosure of Trade Secrets
. During employment and after the Termination Date, Grantee shall not use or disclose Company’s Trade Secrets so long as they remain Trade Secrets. Nothing in this Agreement shall limit either Grantee’s statutory or other duties not to use or disclose Company’s Trade Secrets, or Company’s remedies in the event Grantee uses or discloses Company’s Trade Secrets.
|
6.
|
Obligations Not to Disclose or Use Confidential Information
. Except as set forth herein or as expressly authorized in writing on behalf of Company, Grantee agrees that while Grantee is employed by Company and during the twelve (12) month period commencing at the Termination Date, Grantee will not use or disclose (except in discharging Grantee’s job duties with Company) any Confidential Information, whether such Confidential Information is in Grantee’s memory or it is set forth electronically, in writing or other form. This prohibition does not prohibit Grantee’s disclosure of information after it ceases to meet the definition of “Confidential Information,” or Grantee’s use of general skills and know-how acquired during and prior to employment by Company, so long as such use does not
|
7.
|
Return of Property; No Copying or Transfer of Documents
. All equipment, books, records, papers, notes, catalogs, compilations of information, data bases, correspondence, recordings, stored data (including but not limited to data or files that exist on any personal computer or other electronic storage device), software, and any physical items, including copies and duplicates, that Grantee generates or develops or which come into Grantee’s possession or control, which relate directly or indirectly to, or are a part of Company’s (or its customers’) business matters, whether of a public nature or not (collectively “Company Records”), shall be and remain the property of Company, and Grantee shall deliver all such materials and items, and any and all copies of them, to Company upon termination of employment. During employment or after Termination Date, Grantee will not copy, duplicate, or otherwise reproduce, or permit copying, duplicating, or reproduction of Company Records without the express written consent of Company, or, as a part of Grantee’s duties performed hereunder for the benefit of Company. Grantee expressly covenants and warrants, upon termination of employment for any reason (or no reason), that Grantee shall promptly deliver to Company any and all originals and copies of Company Records in Grantee’s possession, custody, or control, and that Grantee shall not make, retain, or transfer to any third party any copies thereof. In the event any Confidential Information or Trade Secrets are stored or otherwise kept in or on a computer hard drive or other storage device owned by or otherwise in the possession or control of Grantee (each individually an "Grantee Storage Device"), upon termination of employment Grantee will present every such Grantee Storage Device to Company for inspection and removal of all information regarding Company or its customers (including but not limited to Confidential Information or Trade Secrets) that is stored on the Grantee Storage Device. This Paragraph shall not bar Grantee from retaining Grantee’s own payroll, retirement, insurance, tax, and other personnel documents related to Company.
|
8.
|
Covenants Barring Certain Unfair Activities
. Grantee shall abide by such restrictions in Attachment B hereto. Attachment B is incorporated into and is part of this Agreement.
|
(a)
|
Non-solicitation of Management Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Management Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Management Employee has already ceased employment with Company.
|
(b)
|
Non-solicitation of Key Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Key Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Key Employee has already ceased employment with Company.
|
(c)
|
Non-solicitation of Supervised Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Supervised Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Supervised Employee has already ceased employment with Company.
|
10.
|
Proprietary Creations
. All Proprietary Creations are the sole and exclusive property of the Company whether patentable or registrable or not, and Grantee assigns all of Grantee’s rights, title, and interest in same to the Company. Further, all Proprietary Creations which are copyrightable shall be considered “work(s) made for hire” as that term is defined by U.S. Copyright Law. If for any reason a U.S. Court of competent jurisdiction determines such Proprietary Creations not to be works made for hire, Grantee will assign all rights, title, and interest in such works to the Company and, to the extent permitted by law, Grantee hereby assigns all of Grantee’s rights, title, and interest in such Proprietary Creations to the Company. Grantee will promptly disclose all Proprietary Creations to the Company and, if requested to do so, provide the Company a written description or copy thereof. Grantee is not required to assign rights to any invention for which no equipment, supplies, facility, or trade secret information of the Company was
|
11.
|
Remedies
. In addition to other remedies provided by law or equity, the Parties agree that in the event of any breach or threatened breach of this Agreement, Company may obtain interim or other injunctive relief, in addition to any other remedies available, without the need to post a bond. Grantee further agrees that any breach of this Agreement would result in irreparable harm to Company entitling Company to an injunction prohibiting further breaches of these Paragraphs. The Parties agree that in the event Grantee breaches this Agreement, Grantee shall pay the Company’s reasonable attorney’s fees and costs arising out of any litigation resulting from Grantee’s breach.
|
12.
|
Assignmen
t. Company may assign its rights under the Agreement to any assignee or successor. Such assignment shall not require the authorization of Grantee. Grantee may not assign or delegate Grantee’s rights or obligations under this Agreement.
|
13.
|
Entire Agreement
. This Agreement constitutes the entire agreement and understanding between Company and Grantee concerning the subject matter addressed herein and supersedes and extinguishes any and all other or previous discussions, agreements, or understandings between the Parties regarding the subject matter herein. Notwithstanding this Paragraph 13, this Agreement shall not serve to supersede or extinguish other agreements between Grantee and Company (and their subsidiary or affiliated companies and successors) containing similar provisions and restrictions where such agreements were entered into with Grantee as a term or condition of employment.
|
14.
|
Waiver.
The waiver by any Party of the breach of any covenant or provision in this Agreement shall not operate or be construed as a waiver of any subsequent breach by any Party.
|
15.
|
Invalidity of any Provision
. The provisions of this Agreement are severable, it being the intention of the Parties that should any provision hereof be invalid or unenforceable, such invalidity or unenforceability of any provision shall not affect the remaining provisions hereof, but the same shall remain in full force and effect to the fullest extent permitted by law as if such invalid or unenforceable provision were omitted. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, Company and Grantee agree that such provision is to be reformed to the extent necessary for the provision to be valid and enforceable to the fullest and broadest extent permitted by applicable law, without invalidating the remainder of this Agreement
|
16.
|
Applicable Law and Venue
. The Parties agree that this Agreement shall be governed by and construed in accordance with the internal laws of the State of Wisconsin. Any dispute between the Parties arising out of or related to the terms of this Agreement shall be heard only by the Circuit Court of Waukesha County, Wisconsin, or by the United States District Court for the Eastern District of Wisconsin; and the Parties hereby consent to these courts as the exclusive venues for resolving any such disputes.
|
17.
|
Headings.
Headings in this Agreement are for informational purposes only and shall not be used to construe the intent of this Agreement.
|
18.
|
Counterparts
. This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same agreement.
|
19.
|
Reserved Rights
. Nothing in this Agreement shall serve to limit or restrict Grantee’s right to the following:
|
(a)
|
Immunity
. An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (i) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(b)
|
Use Of Trade Secret Information In Anti-Retaliation Lawsuit
. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (i) files any document containing the trade secret under seal; and (ii) does not disclose the trade secret, except pursuant to court order.
|
20.
|
Reasonableness of Restrictions
. GRANTEE HAS READ THIS AGREEMENT AND AGREES THAT THE RESTRICTIONS ON GRANTEE’S ACTIVITIES OUTLINED IN THIS AGREEMENT ARE REASONABLE AND NECESSARY TO PROTECT COMPANY’S LEGITIMATE BUSINESS INTERESTS, THAT THE CONSIDERATION PROVIDED BY COMPANY IS FAIR AND REASONABLE, AND FURTHER AGREES THAT GIVEN THE IMPORTANCE TO COMPANY OF ITS CONFIDENTIAL INFORMATION, TRADE SECRETS, AND CUSTOMER RELATIONSHIPS, THE POST-EMPLOYMENT RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE. GRANTEE AGREES THAT THE GEOGRAPHIC RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE REASONABLE.
|
(a)
|
“
Competing Product
” means any product or service which is sold or provided in competition with a product or service produced, designed, sold or provided by Grantee, either individually or as part of a team, or by one or more employees or Company business units managed, supervised or directed by Grantee or receiving executive or management support from Grantee during the twelve (12) months immediately preceding the Termination Date.
|
(b)
|
“
Confidential Information
” means information (to the extent it is not a Trade Secret), whether oral, written, recorded magnetically or electronically, or otherwise stored, and whether originated by the Grantee or otherwise coming into the possession or knowledge of the Grantee, which is possessed by or developed for Company, and which relates to Company’s existing or potential business, which information is not reasonably ascertainable by Company’s competitors or by the general public through lawful means, and which information Company treats as confidential, including but not limited to information regarding Company’s business affairs, PSA Agreements, strategies, products, finances, costs, margins, computer programs, research, customers, purchasing, marketing, and other information.
|
(c)
|
“
Current Pending Customer
” means a person or entity concerning which Company is actively preparing a business proposal to a prospective customer of the Company as of the Termination Date, or for which Company has a pending proposal to provide goods or services as a Company to a prospect customer as of the Termination Date. However, the term “Current Pending Customer” is limited to persons or entities that Grantee interacts with on behalf of the Company or concerning which Grantee learns, creates or reviews Confidential Information or Trade Secrets on behalf of the Company in the three (3) month period immediately preceding the Grantee’s end of employment with the Company.
|
(d)
|
“
Key Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person is in possession of Confidential Information and/or Trade Secrets.
|
(e)
|
“
Key Services
” means services of the type performed by a Management Employee, Key Employee or Supervised Employee for the Company during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(f)
|
“
Management Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date and such person is a manager, officer, director, or executive of Company.
|
(g)
|
“
Proprietary Creations
” means all inventions, discoveries, designs, improvements, creations, and works conceived, authored, or developed by Grantee, either individually or with others, any time during Grantee’s employment with the Company that: (1) relate to the Company’s current or contemplated business or activities; (2) relate to the Company’s actual or demonstrably anticipated research or development; (3) result from any work performed by Grantee for the Company; (4) involve the use of Company equipment, supplies, facilities, Confidential Information or Trade Secrets; (5) result from or are suggested by any work done by the Company or at the Company’s request, or any projects specifically assigned to Grantee; or (6) result from Grantee’s access to any Company memoranda, notes, records, drawings, sketches, models, maps, customer lists, research results, data, formulae, specifications, inventions, processes, equipment Confidential Information, Trade Secrets or other materials.
|
(h)
|
“
Referral Client
” means a person or entity that does not directly purchase products or services from Company, but which has the ability to effectively specify or recommend the purchase of products or services from Company or its competitors to end customers. The term Referral Client is limited to persons or entities to or through which Grantee, one or more individuals or Company business units supervised, managed or directed by Grantee, markets or sells Company products or services during the twelve (12) month period immediately preceding the Termination Date. The term Referral Client is further restricted to persons or entities which have specified or recommended the purchase of in excess of fifty thousand dollars (US $50,000) worth of products or services
|
(i)
|
“
Restricted Customer
” means a customer of Company to which Grantee, or one or more individuals or Company business units supervised, managed, or directed by Grantee, sells or provides products or services on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Restricted Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(j)
|
“
Restricted Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, Grantee, or one or more other Company employees or Company business units supervised, managed or directed by or receiving management or executive support from Grantee: (i) provides products or services on behalf of the Company; or (ii) sells or solicits the sale of products or services on behalf of the Company. Notwithstanding the foregoing, the term Restricted Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(k)
|
“
Sales Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, the Company: (i) sells products or services designed, developed, tested, or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee; or (ii) provides products or services designed, developed, tested or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee. Notwithstanding the foregoing, the term Sales Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(l)
|
“
Services
” means services of the type performed for Company by Grantee or one or more Company employees managed, supervised, or directed by Grantee during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(m)
|
“
Strategic Customer
” means a customer of Company that purchases or receives a product or service from Company during the twelve (12) month period immediately preceding the Termination Date, but is limited to customers concerning which Grantee learns, creates, or reviews Confidential Information or Trade Secrets on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Strategic Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(n)
|
“
Supervised Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person was directly managed by or reported to Grantee during the last 12 months prior to the Termination Date.
|
(o)
|
“
Termination Date
” means the last date that Grantee serves as an employee of the Company.
|
(p)
|
“
Third Party Confidential Information
” means information received by Company from others that Company has an obligation to treat as confidential.
|
(q)
|
“
Trade Secret
” means a Trade Secret as that term is defined under applicable state or federal law.
|
(r)
|
“
Territory
” means a county within the United States of America, or a city, town or other municipality within a foreign nation.
|
1.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
2.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling, or soliciting the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
3.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Restricted Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
4.
|
For twelve (12) months following Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
5.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
6.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Strategic Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
7.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
8.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
9.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Referral Client to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
10.
|
For three (3) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Current Pending Customer or assist others in doing so.
|
11.
|
For twelve (12) months following Termination Date, Grantee shall not accept a position or provide services to a competitor in any capacity in which it is reasonably likely that Grantee would inevitably use or disclose the Company’s Confidential Information or Trade Secrets. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor.
|
12.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Restricted Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in sales, sales management, or served as an executive or officer of the Company.
|
13.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing, or producing Competing Products for sale in the Restricted Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
14.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Sales Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
15.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing or producing Competing Products for sale in the Sales Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
Performance Objective
|
Minimum
|
Target
|
Maximum
|
FCF Conversion
|
100%
|
115%
|
140%
|
Performance Shares Earned
|
50%
|
100%
|
150%
|
a.
|
as a result of death
|
b.
|
as a result of total and permanent disability, as determined by the Committee in its sole and complete discretion, or
|
c.
|
with respect to a Grantee who has been employed by the Company for at least eight years, as a result of retirement on or after Grantee attaining age 60,
|
1.
|
Incorporation or recitals
. The above recitals are incorporated herein as part of the Agreement.
|
2.
|
Definitions
. Unless otherwise defined herein, the capitalized terms set forth in this Agreement shall have the definitions as set forth in Attachment A. Attachment A is incorporated into and is part of this Agreement.
|
3.
|
Duty of Loyalty
. Grantee acknowledges that Grantee is a key employee of the Company and owes the Company a fiduciary duty of loyalty. During employment with Company, Grantee shall owe Company an undivided duty of loyalty, and shall take no action adverse to that duty of loyalty. Grantee’s duty of loyalty to Company includes but is not limited to a duty to promptly disclose to Company any information that might cause Company to take or refrain from taking any action, or which otherwise might cause Company to alter its behavior. Without limiting the generality of the foregoing, Grantee shall promptly notify Company at any time that Grantee decides to terminate employment with Company or enter into competition with Company, as Company may decide at such time to limit, suspend, or terminate Grantee’s employment or access to Company’s Confidential Information, Trade Secrets, and/or customer relationships. Grantee’s privilege to access and use Company’s computers, and to access and use Company’s electronically stored information including Company’s Confidential Information and Trade Secrets, are revoked the moment Grantee takes any action adverse to Grantee’s duty of loyalty to Company.
|
4.
|
Nondisclosure of Third Party Confidential Information
. During Grantee’s employment with Company and after the Termination Date, Grantee shall not use or disclose Third Party Confidential Information for as long as the relevant third party has required Company to maintain its confidentiality, or for so long as required by applicable law, whichever period is longer.
|
5.
|
Non-disclosure of Trade Secrets
. During employment and after the Termination Date, Grantee shall not use or disclose Company’s Trade Secrets so long as they remain Trade Secrets. Nothing in this Agreement shall limit either Grantee’s statutory or other duties not to use or disclose Company’s Trade Secrets, or Company’s remedies in the event Grantee uses or discloses Company’s Trade Secrets.
|
6.
|
Obligations Not to Disclose or Use Confidential Information
. Except as set forth herein or as expressly authorized in writing on behalf of Company, Grantee agrees that while Grantee is employed by Company and during the twelve (12) month period commencing at the Termination Date, Grantee will not use or disclose (except in discharging Grantee’s
|
7.
|
Return of Property; No Copying or Transfer of Documents
. All equipment, books, records, papers, notes, catalogs, compilations of information, data bases, correspondence, recordings, stored data (including but not limited to data or files that exist on any personal computer or other electronic storage device), software, and any physical items, including copies and duplicates, that Grantee generates or develops or which come into Grantee’s possession or control, which relate directly or indirectly to, or are a part of Company’s (or its customers’) business matters, whether of a public nature or not (collectively “Company Records”), shall be and remain the property of Company, and Grantee shall deliver all such materials and items, and any and all copies of them, to Company upon termination of employment. During employment or after Termination Date, Grantee will not copy, duplicate, or otherwise reproduce, or permit copying, duplicating, or reproduction of Company Records without the express written consent of Company, or, as a part of Grantee’s duties performed hereunder for the benefit of Company. Grantee expressly covenants and warrants, upon termination of employment for any reason (or no reason), that Grantee shall promptly deliver to Company any and all originals and copies of Company Records in Grantee’s possession, custody, or control, and that Grantee shall not make, retain, or transfer to any third party any copies thereof. In the event any Confidential Information or Trade Secrets are stored or otherwise kept in or on a computer hard drive or other storage device owned by or otherwise in the possession or control of Grantee (each individually an "Grantee Storage Device"), upon termination of employment Grantee will present every such Grantee Storage Device to Company for inspection and removal of all information regarding Company or its customers (including but not limited to Confidential Information or Trade Secrets) that is stored on the Grantee Storage Device. This Paragraph shall not bar Grantee from retaining Grantee’s own payroll, retirement, insurance, tax, and other personnel documents related to Company.
|
8.
|
Covenants Barring Certain Unfair Activities
. Grantee shall abide by such restrictions in Attachment B hereto. Attachment B is incorporated into and is part of this Agreement.
|
(a)
|
Non-solicitation of Management Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Management Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Management Employee has already ceased employment with Company.
|
(b)
|
Non-solicitation of Key Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Key Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Key Employee has already ceased employment with Company.
|
(c)
|
Non-solicitation of Supervised Employees. For twelve (12) months following the Termination Date, Grantee shall not, without the prior written consent of Company, encourage, cause, or solicit, or assist others in encouraging, causing, or soliciting, a Supervised Employee to terminate their employment with Company to provide Key Services in competition with Company, unless such Supervised Employee has already ceased employment with Company.
|
10.
|
Proprietary Creations
. All Proprietary Creations are the sole and exclusive property of the Company whether patentable or registrable or not, and Grantee assigns all of Grantee’s rights, title, and interest in same to the Company. Further, all Proprietary Creations which are copyrightable shall be considered “work(s) made for hire” as that term is defined by U.S. Copyright Law. If for any reason a U.S. Court of competent jurisdiction determines such Proprietary Creations not to be works made for hire, Grantee will assign all rights, title, and interest in such works to the Company
|
11.
|
Remedies
. In addition to other remedies provided by law or equity, the Parties agree that in the event of any breach or threatened breach of this Agreement, Company may obtain interim or other injunctive relief, in addition to any other remedies available, without the need to post a bond. Grantee further agrees that any breach of this Agreement would result in irreparable harm to Company entitling Company to an injunction prohibiting further breaches of these Paragraphs. The Parties agree that in the event Grantee breaches this Agreement, Grantee shall pay the Company’s reasonable attorney’s fees and costs arising out of any litigation resulting from Grantee’s breach.
|
12.
|
Assignmen
t. Company may assign its rights under the Agreement to any assignee or successor. Such assignment shall not require the authorization of Grantee. Grantee may not assign or delegate Grantee’s rights or obligations under this Agreement.
|
13.
|
Entire Agreement
. This Agreement constitutes the entire agreement and understanding between Company and Grantee concerning the subject matter addressed herein and supersedes and extinguishes any and all other or previous discussions, agreements, or understandings between the Parties regarding the subject matter herein. Notwithstanding this Paragraph 13, this Agreement shall not serve to supersede or extinguish other agreements between Grantee and Company (and their subsidiary or affiliated companies and successors) containing similar provisions and restrictions where such agreements were entered into with Grantee as a term or condition of employment.
|
14.
|
Waiver.
The waiver by any Party of the breach of any covenant or provision in this Agreement shall not operate or be construed as a waiver of any subsequent breach by any Party.
|
15.
|
Invalidity of any Provision
. The provisions of this Agreement are severable, it being the intention of the Parties that should any provision hereof be invalid or unenforceable, such invalidity or unenforceability of any provision shall not affect the remaining provisions hereof, but the same shall remain in full force and effect to the fullest extent permitted by law as if such invalid or unenforceable provision were omitted. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, Company and Grantee agree that such provision is to be reformed to the extent necessary for the provision to be valid and enforceable to the fullest and broadest extent permitted by applicable law, without invalidating the remainder of this Agreement
|
16.
|
Applicable Law and Venue
. The Parties agree that this Agreement shall be governed by and construed in accordance with the internal laws of the State of Wisconsin. Any dispute between the Parties arising out of or related to the terms of this Agreement shall be heard only by the Circuit Court of Waukesha County, Wisconsin, or by the United States District Court for the Eastern District of Wisconsin; and the Parties hereby consent to these courts as the exclusive venues for resolving any such disputes.
|
17.
|
Headings.
Headings in this Agreement are for informational purposes only and shall not be used to construe the intent of this Agreement.
|
18.
|
Counterparts
. This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same agreement.
|
19.
|
Reserved Rights
. Nothing in this Agreement shall serve to limit or restrict Grantee’s right to the following:
|
(a)
|
Immunity
. An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (i) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(b)
|
Use Of Trade Secret Information In Anti-Retaliation Lawsuit
. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (i) files any document containing the trade secret under seal; and (ii) does not disclose the trade secret, except pursuant to court order.
|
20.
|
Reasonableness of Restrictions
. GRANTEE HAS READ THIS AGREEMENT AND AGREES THAT THE RESTRICTIONS ON GRANTEE’S ACTIVITIES OUTLINED IN THIS AGREEMENT ARE REASONABLE AND NECESSARY TO PROTECT COMPANY’S LEGITIMATE BUSINESS INTERESTS, THAT THE CONSIDERATION PROVIDED BY COMPANY IS FAIR AND REASONABLE, AND FURTHER AGREES THAT GIVEN THE IMPORTANCE TO COMPANY OF ITS CONFIDENTIAL INFORMATION, TRADE SECRETS, AND CUSTOMER RELATIONSHIPS, THE POST-EMPLOYMENT RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE. GRANTEE AGREES THAT THE GEOGRAPHIC RESTRICTIONS ON GRANTEE’S ACTIVITIES ARE REASONABLE.
|
(a)
|
“
Competing Product
” means any product or service which is sold or provided in competition with a product or service produced, designed, sold or provided by Grantee, either individually or as part of a team, or by one or more employees or Company business units managed, supervised or directed by Grantee or receiving executive or management support from Grantee during the twelve (12) months immediately preceding the Termination Date.
|
(b)
|
“
Confidential Information
” means information (to the extent it is not a Trade Secret), whether oral, written, recorded magnetically or electronically, or otherwise stored, and whether originated by the Grantee or otherwise coming into the possession or knowledge of the Grantee, which is possessed by or developed for Company, and which relates to Company’s existing or potential business, which information is not reasonably ascertainable by Company’s competitors or by the general public through lawful means, and which information Company treats as confidential, including but not limited to information regarding Company’s business affairs, PSA Agreements, strategies, products, finances, costs, margins, computer programs, research, customers, purchasing, marketing, and other information.
|
(c)
|
“
Current Pending Customer
” means a person or entity concerning which Company is actively preparing a business proposal to a prospective customer of the Company as of the Termination Date, or for which Company has a pending proposal to provide goods or services as a Company to a prospect customer as of the Termination Date. However, the term “Current Pending Customer” is limited to persons or entities that Grantee interacts with on behalf of the Company or concerning which Grantee learns, creates or reviews Confidential Information or Trade Secrets on behalf of the Company in the three (3) month period immediately preceding the Grantee’s end of employment with the Company.
|
(d)
|
“
Key Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person is in possession of Confidential Information and/or Trade Secrets.
|
(e)
|
“
Key Services
” means services of the type performed by a Management Employee, Key Employee or Supervised Employee for the Company during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(f)
|
“
Management Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date and such person is a manager, officer, director, or executive of Company.
|
(g)
|
“
Proprietary Creations
” means all inventions, discoveries, designs, improvements, creations, and works conceived, authored, or developed by Grantee, either individually or with others, any time during Grantee’s employment with the Company that: (1) relate to the Company’s current or contemplated business or activities; (2) relate to the Company’s actual or demonstrably anticipated research or development; (3) result from any work performed by Grantee for the Company; (4) involve the use of Company equipment, supplies, facilities, Confidential Information or Trade Secrets; (5) result from or are suggested by any work done by the Company or at the Company’s request, or any projects specifically assigned to Grantee; or (6) result from Grantee’s access to any Company memoranda, notes, records, drawings, sketches, models, maps, customer lists, research results, data, formulae, specifications, inventions, processes, equipment Confidential Information, Trade Secrets or other materials.
|
(h)
|
“
Referral Client
” means a person or entity that does not directly purchase products or services from Company, but which has the ability to effectively specify or recommend the purchase of products or services from Company or its competitors to end customers. The term Referral Client is limited to persons or entities to or through which Grantee, one or more individuals or Company business units supervised, managed or directed by Grantee, markets or sells Company products or services during the twelve (12) month period immediately preceding the Termination Date. The term Referral Client is further restricted to persons or entities which have specified or recommended the purchase of in excess of fifty thousand dollars (US $50,000) worth of products or services
|
(i)
|
“
Restricted Customer
” means a customer of Company to which Grantee, or one or more individuals or Company business units supervised, managed, or directed by Grantee, sells or provides products or services on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Restricted Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(j)
|
“
Restricted Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, Grantee, or one or more other Company employees or Company business units supervised, managed or directed by or receiving management or executive support from Grantee: (i) provides products or services on behalf of the Company; or (ii) sells or solicits the sale of products or services on behalf of the Company. Notwithstanding the foregoing, the term Restricted Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(k)
|
“
Sales Territory
” means Territories in which, during the twelve (12) month period immediately preceding the Termination Date, the Company: (i) sells products or services designed, developed, tested, or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee; or (ii) provides products or services designed, developed, tested or produced by Grantee (either individually or in collaboration with other Company employees) or by one or more other Company employees or business units managed or directed by or receiving executive or management support from Grantee. Notwithstanding the foregoing, the term Sales Territory is limited to Territories in which Company sells or provides in excess of one hundred thousand dollars (US $100,000) in the aggregate worth of products or services in the twelve (12) month period immediately preceding the Termination Date.
|
(l)
|
“
Services
” means services of the type performed for Company by Grantee or one or more Company employees managed, supervised, or directed by Grantee during the final twelve (12) months preceding the Termination Date, but shall not include clerical, menial, or manual labor.
|
(m)
|
“
Strategic Customer
” means a customer of Company that purchases or receives a product or service from Company during the twelve (12) month period immediately preceding the Termination Date, but is limited to customers concerning which Grantee learns, creates, or reviews Confidential Information or Trade Secrets on behalf of Company during the twelve (12) month period immediately preceding the Termination Date. The term Strategic Customer is limited to Company customers that purchase or receive in excess of fifty thousand dollars (US $50,000) worth of products or services from Company during the twelve (12) month period immediately preceding the Termination Date.
|
(n)
|
“
Supervised Employee
” means any person who at the Termination Date is employed or engaged by Company, and with whom Grantee has had material contact in the course of employment during the twelve (12) months immediately preceding the Termination Date, and such person was directly managed by or reported to Grantee during the last 12 months prior to the Termination Date.
|
(o)
|
“
Termination Date
” means the last date that Grantee serves as an employee of the Company.
|
(p)
|
“
Third Party Confidential Information
” means information received by Company from others that Company has an obligation to treat as confidential.
|
(q)
|
“
Trade Secret
” means a Trade Secret as that term is defined under applicable state or federal law.
|
(r)
|
“
Territory
” means a county within the United States of America, or a city, town or other municipality within a foreign nation.
|
1.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
2.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling, or soliciting the sale of a Competing Product to a Restricted Customer or assist others in doing so.
|
3.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Restricted Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
4.
|
For twelve (12) months following Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
5.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to a Strategic Customer or assist others in doing so.
|
6.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Strategic Customer to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
7.
|
For twelve (12) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
8.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of providing, selling or soliciting the sale of a Competing Product to or through a Referral Client or assist others in doing so.
|
9.
|
For twelve (12) months following Termination Date, Grantee shall not encourage or cause a Referral Client to curtail, withdraw or cancel any business with Company or assist others in doing so.
|
10.
|
For three (3) months following the Termination Date, Grantee shall not sell or solicit the sale of a Competing Product to a Current Pending Customer or assist others in doing so.
|
11.
|
For twelve (12) months following Termination Date, Grantee shall not accept a position or provide services to a competitor in any capacity in which it is reasonably likely that Grantee would inevitably use or disclose the Company’s Confidential Information or Trade Secrets. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor.
|
12.
|
For twelve (12) months following Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Restricted Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in sales, sales management, or served as an executive or officer of the Company.
|
13.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing, or producing Competing Products for sale in the Restricted Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
14.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of the business of selling, providing or soliciting the sale of Competing Products in the Sales Territory. This Paragraph shall not bar Grantee from performing clerical, menial or manual labor. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
15.
|
For twelve (12) months following the Termination Date, Grantee shall not perform Services as part of or in support of developing, designing, testing or producing Competing Products for sale in the Sales Territory. This Paragraph shall apply to Grantee only if during the one (1) year period immediately preceding the Termination Date Grantee is involved in product development design, testing, production, or served as an executive or officer of the Company.
|
|
|
|
NAME OF SUBSIDIARY:
|
|
STATE/COUNTRY OF INCORPORATION:
|
Hydratight Angola Lda
|
|
Angola
|
Actuant Australia Pty. Ltd.
|
|
Australia
|
Actuant Energy Pty. Ltd.
|
|
Australia
|
Cortland Company Australia Pty. Ltd.
|
|
Australia
|
Hydratight (Asia Pacific) Pty. Ltd.
|
|
Australia
|
Hydratight Equipamentos Servicos e Industria Ltda.
|
|
Brazil
|
Power Packer do Brazil Ltda.
|
|
Brazil
|
Turotest Medidores Ltda.
|
|
Brazil
|
Actuant Canada Corporation
|
|
Canada
|
Actuant Changchun Co. Ltd.
|
|
China
|
Actuant China Industries Co. Ltd.
|
|
China
|
Actuant China Ltd.
|
|
China
|
Actuant Shanghai Trading Co. Ltd.
|
|
China
|
Actuant Cyprus Ltd
|
|
Cyprus
|
Actuant International Holdings, Inc.
|
|
Delaware
|
Actuant UK Holdings, LLC
|
|
Delaware
|
Cortland Company, Inc
|
|
Delaware
|
ATU Worldwide Holdings II LLC
|
|
Delaware
|
Hydratight Operations, Inc.
|
|
Delaware
|
Maxima Holding Company Inc.
|
|
Delaware
|
Maxima Holdings Europe, Inc
|
|
Delaware
|
Maxima Technologies & Systems, LLC.
|
|
Delaware
|
Power Packer North America, Inc.
|
|
Delaware
|
Precision-Hayes International Inc.
|
|
Delaware
|
Versa Technologies, Inc.
|
|
Delaware
|
Weasler Engineering, Inc
|
|
Delaware
|
CrossControl OY
|
|
Finland
|
Actuant Europe Holdings SAS
|
|
France
|
Actuant France SAS
|
|
France
|
Hydratight SAS
|
|
France
|
Yvel SAS
|
|
France
|
Actuant GmbH
|
|
Germany
|
Hydratight Injectaseal Deutschland GmbH
|
|
Germany
|
Actuant Global Sourcing, Ltd.
|
|
Hong Kong
|
Actuant International Services, Ltd.
|
|
Hong Kong
|
Mastervolt Asia Ltd.
|
|
Hong Kong
|
Actuant Hungary Holding Kft.
|
|
Hungary
|
Actuant Hungary Kft.
|
|
Hungary
|
ATU Hungary Holding Kft.
|
|
Hungary
|
Weasler Engineering Kft.
|
|
Hungary
|
Actuant India Pvt. Ltd.
|
|
India
|
Engineered Solutions LP
|
|
Indiana
|
Enerpac SpA
|
|
Italy
|
Enerpac Co. Ltd
|
|
Japan
|
AE Investments I Ltd.
|
|
Jersey
|
AE Investments II Ltd.
|
|
Jersey
|
MT&S Europe, S.a.r.l.
|
|
Luxembourg
|
CrossControl Sdn. Bhd.
|
|
Malaysia
|
Actuant Mexico Holdings S. de R.L. de C.V.
|
|
Mexico
|
Instrumentos Stewart Warner de Mexico S.A. de C.V.
|
|
Mexico
|
Actuant Europe CV
|
|
Netherlands
|
Applied Power Europa BV
|
|
Netherlands
|
ATU Euro Finance BV
|
|
Netherlands
|
ATU Global Holdings CV
|
|
Netherlands
|
ATU Global Holdings II BV
|
|
Netherlands
|
BML Global Holdings CV
|
|
Netherlands
|
Enerpac BV
|
|
Netherlands
|
Enerpac Heavy Lifting Technology BV
|
|
Netherlands
|
Engineered Solutions Holdings CV
|
|
Netherlands
|
Hydratight BV
|
|
Netherlands
|
Power Packer Europa BV
|
|
Netherlands
|
Weasler Engineering BV
|
|
Netherlands
|
Actuant Investments, Inc.
|
|
Nevada
|
ATU M.E. Investments, LLC
|
|
Nevada
|
ATU Worldwide Holdings I Inc.
|
|
New York
|
BW Elliott Mfg. Co., LLC
|
|
New York
|
Hydratight Norge AS
|
|
Norway
|
Selantic AS
|
|
Norway
|
Venice Holdings AS
|
|
Norway
|
Venice Norge AS
|
|
Norway
|
Actuant Russia LLC
|
|
Russia
|
Actuant Asia Pte. Ltd.
|
|
Singapore
|
Enerpac Asia Pte. Ltd.
|
|
Singapore
|
Actuant Operations Singapore Pte Ltd.
|
|
Singapore
|
Venice (Singapore) Pte Ltd.
|
|
Singapore
|
Venice Holdings (Singapore) Pte Ltd.
|
|
Singapore
|
Enerpac Africa (Pty) Ltd.
|
|
South Africa
|
Actuant Korea Ltd.
|
|
South Korea
|
Actuant Middle East Holdings, S.L.
|
|
Spain
|
Enerpac Spain, S.L.
|
|
Spain
|
Larzep, S.A.
|
|
Spain
|
Maxima Spain Holdings, S.L.
|
|
Spain
|
Maxima Technologies, S.L.
|
|
Spain
|
Actuant Holdings AB
|
|
Sweden
|
Actuant Sweden HB
|
|
Sweden
|
CrossCo Investment AB
|
|
Sweden
|
CrossControl AB
|
|
Sweden
|
Enerpac Scandinavia AB
|
|
Sweden
|
Equalizer Flange Tool Innovation Co. Ltd.
|
|
Taiwan
|
Equalizer International Inc.
|
|
Texas
|
PSL Holdings, Inc.
|
|
Texas
|
Hydratight Ltd.
|
|
Trinidad
|
Ergun Hidrolik Sanayi VE Ticaret A.S.
|
|
Turkey
|
Actuant Acquisitions Ltd.
|
|
UK
|
Actuant Acquisitions Finance Ltd.
|
|
UK
|
Actuant Energy Ltd.
|
|
UK
|
Actuant Finance Ltd
|
|
UK
|
Actuant Global Financing Limited
|
|
UK
|
Actuant Ltd.
|
|
UK
|
Actuant International Ltd.
|
|
UK
|
Actuant Operations UK Ltd.
|
|
UK
|
AE Holdings Ltd.
|
|
UK
|
ATU Asia Holdings Ltd.
|
|
UK
|
ATU Investments Ltd
|
|
UK
|
BML PN Ltd
|
|
UK
|
CAM 1 Ltd
|
|
UK
|
Cortland Fibron BX Ltd.
|
|
UK
|
Cortland UK Holdings Ltd.
|
|
UK
|
D.L. Ricci Ltd.
|
|
UK
|
Equalizer Flange Integrity Systems Ltd.
|
|
UK
|
Equalizer International Ltd.
|
|
UK
|
HT Global Holdings Limited
|
|
UK
|
Hydratight Ltd.
|
|
UK
|
Hydratight Operations, Ltd.
|
|
UK
|
Mirage Machines Limited
|
|
UK
|
Venice Fundco Ltd.
|
|
UK
|
Venice Topco Ltd.
|
|
UK
|
Enerpac Middle East FZE
|
|
United Arab Emirates
|
Hydratight FZE
|
|
United Arab Emirates
|
|
|
|
|
|
|
1.
|
I have reviewed this annual report on Form 10-K of Actuant Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting
|
|
/s/ Randal W. Baker
|
|
Randal W. Baker
President and Chief Executive Officer
|
1.
|
I have reviewed this annual report on Form 10-K of Actuant Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting
|
|
/s/ Rick T. Dillon
|
|
Rick T. Dillon
Executive Vice President and
Chief Financial Officer
|
|
/s/ Randal W. Baker
|
|
Randal W. Baker
|
|
/s/ Rick T. Dillon
|
|
Rick T. Dillon
|